pathwayName,sourceId,type,metabolite
Glutamate Metabolism,SMP00072,hmdb,ABAT
Gamma-glutamyl-transpeptidase deficiency,SMP00501,hmdb,ANPEP
Bupranolol Action Pathway,SMP00670,hmdb,ATP1A2
Bupranolol Action Pathway,SMP00670,hmdb,MYLK
Bupranolol Action Pathway,SMP00670,hmdb,CACNA1C
Bupranolol Action Pathway,SMP00670,hmdb,CACNA1G
Bupranolol Action Pathway,SMP00670,hmdb,CACNB1
Bupranolol Action Pathway,SMP00670,hmdb,KCNIP2
Fentanyl Pathway,SMP00415,hmdb,KCNIP2
Fentanyl Pathway,SMP00415,hmdb,CACNB1
Fentanyl Pathway,SMP00415,hmdb,ATP1A2
"Glycogenosis, Type VI. Hers disease",SMP00555,hmdb,AMY1A
Bopindolol Action Pathway,SMP00657,hmdb,CACNA1C
Bopindolol Action Pathway,SMP00657,hmdb,ATP1A2
Bopindolol Action Pathway,SMP00657,hmdb,MYLK
Bopindolol Action Pathway,SMP00657,hmdb,KCNIP2
Bopindolol Action Pathway,SMP00657,hmdb,CACNA1G
Bopindolol Action Pathway,SMP00657,hmdb,CACNB1
Bumetanide Pathway,SMP00088,hmdb,ATP1A2
Bumetanide Pathway,SMP00088,hmdb,SLC14A2
Methadone Pathway,SMP00408,hmdb,KCNIP2
Methadone Pathway,SMP00408,hmdb,ATP1A2
Methadone Pathway,SMP00408,hmdb,CACNB1
Spironolactone Pathway,SMP00134,hmdb,SLC14A2
Spironolactone Pathway,SMP00134,hmdb,ATP1A2
Beta-Ketothiolase Deficiency,SMP00173,hmdb,ACADS
Beta-Ketothiolase Deficiency,SMP00173,hmdb,ABAT
Amlodipine Pathway,SMP00376,hmdb,CACNB1
Amlodipine Pathway,SMP00376,hmdb,ATP1A2
Amlodipine Pathway,SMP00376,hmdb,CACNA1C
Amlodipine Pathway,SMP00376,hmdb,CACNA1G
Amlodipine Pathway,SMP00376,hmdb,KCNIP2
Amlodipine Pathway,SMP00376,hmdb,MYLK
"Glycogenosis, Type IV. Amylopectinosis, Anderson disease",SMP00554,hmdb,AMY1A
Bevantolol Action Pathway,SMP00668,hmdb,CACNA1C
Bevantolol Action Pathway,SMP00668,hmdb,ATP1A2
Bevantolol Action Pathway,SMP00668,hmdb,CACNB1
Bevantolol Action Pathway,SMP00668,hmdb,KCNIP2
Bevantolol Action Pathway,SMP00668,hmdb,MYLK
Bevantolol Action Pathway,SMP00668,hmdb,CACNA1G
Levobunolol Action Pathway,SMP00666,hmdb,ATP1A2
Levobunolol Action Pathway,SMP00666,hmdb,CACNB1
Levobunolol Action Pathway,SMP00666,hmdb,CACNA1G
Levobunolol Action Pathway,SMP00666,hmdb,CACNA1C
Levobunolol Action Pathway,SMP00666,hmdb,MYLK
Levobunolol Action Pathway,SMP00666,hmdb,KCNIP2
Dihydromorphine Action Pathway,SMP00689,hmdb,KCNIP2
Dihydromorphine Action Pathway,SMP00689,hmdb,CACNB1
Dihydromorphine Action Pathway,SMP00689,hmdb,ATP1A2
Lactic Acidemia,SMP00313,hmdb,AARS2
Doxorubicin Metabolism Pathway,SMP00650,hmdb,ABCB1
Pyrimidine Metabolism,SMP00046,hmdb,NT5C2
Repaglinide Pathway,SMP00454,hmdb,CACNB1
Methadyl Acetate Action Pathway,SMP00678,hmdb,ATP1A2
Methadyl Acetate Action Pathway,SMP00678,hmdb,CACNB1
Methadyl Acetate Action Pathway,SMP00678,hmdb,KCNIP2
Dihydropyrimidinase Deficiency,SMP00178,hmdb,NT5C2
Metipranolol Action Pathway,SMP00667,hmdb,KCNIP2
Metipranolol Action Pathway,SMP00667,hmdb,CACNA1C
Metipranolol Action Pathway,SMP00667,hmdb,CACNA1G
Metipranolol Action Pathway,SMP00667,hmdb,CACNB1
Metipranolol Action Pathway,SMP00667,hmdb,ATP1A2
Metipranolol Action Pathway,SMP00667,hmdb,MYLK
Lysinuric protein intolerance (LPI),SMP00585,hmdb,SLC14A2
Lysinuric protein intolerance (LPI),SMP00585,hmdb,ATP1A2
5-Oxoprolinuria,SMP00143,hmdb,ANPEP
Paclitaxel Pathway,SMP00434,hmdb,ABCB1
Inositol Metabolism,SMP00011,hmdb,ISYNA1
Inositol Metabolism,SMP00011,hmdb,INPP1
Vincristine Pathway,SMP00437,hmdb,ABCC3
Vincristine Pathway,SMP00437,hmdb,ABCB1
Nifedipine Pathway,SMP00379,hmdb,CACNA1G
Nifedipine Pathway,SMP00379,hmdb,CACNA1C
Nifedipine Pathway,SMP00379,hmdb,KCNIP2
Nifedipine Pathway,SMP00379,hmdb,CACNB1
Nifedipine Pathway,SMP00379,hmdb,MYLK
Nifedipine Pathway,SMP00379,hmdb,ATP1A2
Dimethylglycine Dehydrogenase Deficiency,SMP00242,hmdb,DMGDH
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMP00235,hmdb,ACADS
GABA-Transaminase Deficiency,SMP00351,hmdb,ABAT
Butyrate Metabolism,SMP00073,hmdb,ACADS
Bupivacaine Pathway,SMP00393,hmdb,ATP1A2
Bupivacaine Pathway,SMP00393,hmdb,CACNB1
Bupivacaine Pathway,SMP00393,hmdb,KCNIP2
Myoadenylate deaminase deficiency,SMP00537,hmdb,NT5C2
Nadolol Pathway,SMP00303,hmdb,KCNIP2
Nadolol Pathway,SMP00303,hmdb,MYLK
Nadolol Pathway,SMP00303,hmdb,CACNA1C
Nadolol Pathway,SMP00303,hmdb,CACNB1
Nadolol Pathway,SMP00303,hmdb,ATP1A2
Nadolol Pathway,SMP00303,hmdb,CACNA1G
Oxprenolol Pathway,SMP00304,hmdb,KCNIP2
Oxprenolol Pathway,SMP00304,hmdb,ATP1A2
Oxprenolol Pathway,SMP00304,hmdb,CACNB1
Oxprenolol Pathway,SMP00304,hmdb,MYLK
Oxprenolol Pathway,SMP00304,hmdb,CACNA1G
Oxprenolol Pathway,SMP00304,hmdb,CACNA1C
D-glyceric acidura,SMP00529,hmdb,DGKA
Venlafaxine Metabolism Pathway,SMP00636,hmdb,ABCB1
Citalopram Pathway,SMP00424,hmdb,CACNB1
Citalopram Pathway,SMP00424,hmdb,ATP1A2
Citalopram Pathway,SMP00424,hmdb,KCNIP2
Procaine Pathway,SMP00402,hmdb,KCNIP2
Procaine Pathway,SMP00402,hmdb,CACNB1
Procaine Pathway,SMP00402,hmdb,ATP1A2
Alanine Metabolism,SMP00055,hmdb,AARS2
Oxybuprocaine Pathway,SMP00400,hmdb,KCNIP2
Oxybuprocaine Pathway,SMP00400,hmdb,ATP1A2
Oxybuprocaine Pathway,SMP00400,hmdb,CACNB1
Levorphanol Action Pathway,SMP00673,hmdb,KCNIP2
Levorphanol Action Pathway,SMP00673,hmdb,ATP1A2
Levorphanol Action Pathway,SMP00673,hmdb,CACNB1
Hydroflumethiazide Pathway,SMP00108,hmdb,ATP1A2
Hydroflumethiazide Pathway,SMP00108,hmdb,SLC14A2
Atenolol Pathway,SMP00298,hmdb,KCNIP2
Atenolol Pathway,SMP00298,hmdb,CACNA1C
Atenolol Pathway,SMP00298,hmdb,CACNA1G
Atenolol Pathway,SMP00298,hmdb,MYLK
Atenolol Pathway,SMP00298,hmdb,CACNB1
Atenolol Pathway,SMP00298,hmdb,ATP1A2
"Carnosinuria, carnosinemia",SMP00493,hmdb,ABAT
Codeine Pathway,SMP00405,hmdb,ATP1A2
Codeine Pathway,SMP00405,hmdb,KCNIP2
Codeine Pathway,SMP00405,hmdb,CACNB1
Hyperinsulinism-Hyperammonemia Syndrome,SMP00339,hmdb,ABAT
Kidney Function,SMP00483,hmdb,SLC14A2
Kidney Function,SMP00483,hmdb,ATP1A2
Hartnup Disorder,SMP00189,hmdb,SLC14A2
Hartnup Disorder,SMP00189,hmdb,ATP1A2
Trehalose Degradation,SMP00467,hmdb,TREH
Trehalose Degradation,SMP00467,hmdb,ATP1A2
Nisoldipine Pathway,SMP00381,hmdb,ATP1A2
Nisoldipine Pathway,SMP00381,hmdb,KCNIP2
Nisoldipine Pathway,SMP00381,hmdb,CACNB1
Nisoldipine Pathway,SMP00381,hmdb,CACNA1G
Nisoldipine Pathway,SMP00381,hmdb,MYLK
Nisoldipine Pathway,SMP00381,hmdb,CACNA1C
Bendroflumethiazide Pathway,SMP00090,hmdb,SLC14A2
Bendroflumethiazide Pathway,SMP00090,hmdb,ATP1A2
Ethylmorphine Action Pathway,SMP00681,hmdb,ATP1A2
Ethylmorphine Action Pathway,SMP00681,hmdb,CACNB1
Ethylmorphine Action Pathway,SMP00681,hmdb,KCNIP2
Lactose Intolerance,SMP00458,hmdb,ATP1A2
Beta Ureidopropionase Deficiency,SMP00172,hmdb,NT5C2
Carfentanil Pathway,SMP00414,hmdb,CACNB1
Carfentanil Pathway,SMP00414,hmdb,KCNIP2
Carfentanil Pathway,SMP00414,hmdb,ATP1A2
Alvimopan Action Pathway,SMP00685,hmdb,KCNIP2
Alvimopan Action Pathway,SMP00685,hmdb,CACNB1
Alvimopan Action Pathway,SMP00685,hmdb,ATP1A2
"Hyperglycinemia, non-ketotic",SMP00485,hmdb,DMGDH
Tramadol Action Action Pathway,SMP00671,hmdb,ATP1A2
Tramadol Action Action Pathway,SMP00671,hmdb,KCNIP2
Tramadol Action Action Pathway,SMP00671,hmdb,CACNB1
2-Hydroxyglutric Aciduria (D And L Form),SMP00136,hmdb,ABAT
Remifentanil Pathway,SMP00416,hmdb,CACNB1
Remifentanil Pathway,SMP00416,hmdb,KCNIP2
Remifentanil Pathway,SMP00416,hmdb,ATP1A2
3-Methylglutaconic Aciduria Type IV,SMP00141,hmdb,ACADS
3-Methylglutaconic Aciduria Type IV,SMP00141,hmdb,ABAT
Eplerenone Pathway,SMP00135,hmdb,SLC14A2
Eplerenone Pathway,SMP00135,hmdb,ATP1A2
Felodipine Pathway,SMP00377,hmdb,ATP1A2
Felodipine Pathway,SMP00377,hmdb,KCNIP2
Felodipine Pathway,SMP00377,hmdb,CACNA1C
Felodipine Pathway,SMP00377,hmdb,CACNA1G
Felodipine Pathway,SMP00377,hmdb,MYLK
Felodipine Pathway,SMP00377,hmdb,CACNB1
Isovaleric acidemia,SMP00524,hmdb,ABAT
Isovaleric acidemia,SMP00524,hmdb,ACADS
Fluoxetine Pathway,SMP00426,hmdb,ATP1A2
Fluoxetine Pathway,SMP00426,hmdb,CACNB1
Fluoxetine Pathway,SMP00426,hmdb,KCNIP2
Furosemide Pathway,SMP00115,hmdb,SLC14A2
Furosemide Pathway,SMP00115,hmdb,ATP1A2
Torsemide Pathway,SMP00118,hmdb,ATP1A2
Torsemide Pathway,SMP00118,hmdb,SLC14A2
Nalbuphine Action Pathway,SMP00691,hmdb,CACNB1
Nalbuphine Action Pathway,SMP00691,hmdb,ATP1A2
Nalbuphine Action Pathway,SMP00691,hmdb,KCNIP2
Maple Syrup Urine Disease,SMP00199,hmdb,ACADS
Maple Syrup Urine Disease,SMP00199,hmdb,ABAT
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMP00220,hmdb,NT5C2
Buprenorphine Action Pathway,SMP00684,hmdb,CACNB1
Buprenorphine Action Pathway,SMP00684,hmdb,ATP1A2
Buprenorphine Action Pathway,SMP00684,hmdb,KCNIP2
Adenine phosphoribosyltransferase deficiency (APRT),SMP00535,hmdb,NT5C2
Levallorphan Action Pathway,SMP00683,hmdb,KCNIP2
Levallorphan Action Pathway,SMP00683,hmdb,CACNB1
Levallorphan Action Pathway,SMP00683,hmdb,ATP1A2
Propionic Acidemia,SMP00236,hmdb,ACADS
Propionic Acidemia,SMP00236,hmdb,ABAT
Ibutilide Pathway,SMP00332,hmdb,MYLK
Ibutilide Pathway,SMP00332,hmdb,CACNB1
Ibutilide Pathway,SMP00332,hmdb,KCNIP2
Ibutilide Pathway,SMP00332,hmdb,CACNA1C
Ibutilide Pathway,SMP00332,hmdb,CACNA1G
Ibutilide Pathway,SMP00332,hmdb,ATP1A2
Glutathione Synthetase Deficiency,SMP00337,hmdb,ANPEP
Lesch-Nyhan Syndrome (LNS),SMP00364,hmdb,NT5C2
Dibucaine Pathway,SMP00396,hmdb,ATP1A2
Dibucaine Pathway,SMP00396,hmdb,KCNIP2
Dibucaine Pathway,SMP00396,hmdb,CACNB1
Erlotinib Pathway,SMP00472,hmdb,ABCB1
Hypoacetylaspartia,SMP00192,hmdb,ASNS
Hypoacetylaspartia,SMP00192,hmdb,ABAT
Felodipine Metabolism Pathway,SMP00619,hmdb,CACNA1C
Felodipine Metabolism Pathway,SMP00619,hmdb,CACNB1
Mitochondrial DNA depletion syndrome,SMP00536,hmdb,NT5C2
Anileridine Action Pathway,SMP00674,hmdb,KCNIP2
Anileridine Action Pathway,SMP00674,hmdb,ATP1A2
Anileridine Action Pathway,SMP00674,hmdb,CACNB1
Benzocaine Pathway,SMP00392,hmdb,CACNB1
Benzocaine Pathway,SMP00392,hmdb,KCNIP2
Benzocaine Pathway,SMP00392,hmdb,ATP1A2
Lidocaine (Local Anaesthetic) Pathway,SMP00398,hmdb,CACNB1
Lidocaine (Local Anaesthetic) Pathway,SMP00398,hmdb,KCNIP2
Lidocaine (Local Anaesthetic) Pathway,SMP00398,hmdb,ATP1A2
Thioguanine Pathway,SMP00430,hmdb,NT5C2
Cyclothiazide Pathway,SMP00103,hmdb,SLC14A2
Cyclothiazide Pathway,SMP00103,hmdb,ATP1A2
Gliclazide Pathway,SMP00461,hmdb,CACNB1
Verapamil Pathway,SMP00375,hmdb,CACNB1
Verapamil Pathway,SMP00375,hmdb,CACNA1G
Verapamil Pathway,SMP00375,hmdb,KCNIP2
Verapamil Pathway,SMP00375,hmdb,CACNA1C
Verapamil Pathway,SMP00375,hmdb,ATP1A2
Verapamil Pathway,SMP00375,hmdb,MYLK
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMP00568,hmdb,ACADS
Glucose Transporter Defect (SGLT2),SMP00184,hmdb,SLC14A2
Glucose Transporter Defect (SGLT2),SMP00184,hmdb,ATP1A2
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMP00480,hmdb,ACADS
Bisoprolol Pathway,SMP00300,hmdb,CACNA1C
Bisoprolol Pathway,SMP00300,hmdb,CACNB1
Bisoprolol Pathway,SMP00300,hmdb,ATP1A2
Bisoprolol Pathway,SMP00300,hmdb,KCNIP2
Bisoprolol Pathway,SMP00300,hmdb,CACNA1G
Bisoprolol Pathway,SMP00300,hmdb,MYLK
Mepivacaine Pathway,SMP00399,hmdb,KCNIP2
Mepivacaine Pathway,SMP00399,hmdb,CACNB1
Mepivacaine Pathway,SMP00399,hmdb,ATP1A2
Vindesine Pathway,SMP00438,hmdb,ABCC3
Vindesine Pathway,SMP00438,hmdb,ABCB1
3-hydroxyisobutyric acid dehydrogenase deficiency,SMP00521,hmdb,ACADS
3-hydroxyisobutyric acid dehydrogenase deficiency,SMP00521,hmdb,ABAT
Ureidopropionase deficiency,SMP00492,hmdb,ABAT
Oxymorphone Pathway,SMP00412,hmdb,CACNB1
Oxymorphone Pathway,SMP00412,hmdb,ATP1A2
Oxymorphone Pathway,SMP00412,hmdb,KCNIP2
Purine Nucleoside Phosphorylase Deficiency,SMP00210,hmdb,NT5C2
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMP00243,hmdb,ABAT
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMP00201,hmdb,ABAT
Aspartate Metabolism,SMP00067,hmdb,ABAT
Aspartate Metabolism,SMP00067,hmdb,ASNS
Chloroprocaine Pathway,SMP00394,hmdb,ATP1A2
Chloroprocaine Pathway,SMP00394,hmdb,KCNIP2
Chloroprocaine Pathway,SMP00394,hmdb,CACNB1
Sotalol Action Pathway,SMP00660,hmdb,ATP1A2
Sotalol Action Pathway,SMP00660,hmdb,CACNB1
Sotalol Action Pathway,SMP00660,hmdb,MYLK
Sotalol Action Pathway,SMP00660,hmdb,KCNIP2
Sotalol Action Pathway,SMP00660,hmdb,CACNA1C
Sotalol Action Pathway,SMP00660,hmdb,CACNA1G
Nimodipine Pathway,SMP00380,hmdb,MYLK
Nimodipine Pathway,SMP00380,hmdb,ATP1A2
Nimodipine Pathway,SMP00380,hmdb,CACNB1
Nimodipine Pathway,SMP00380,hmdb,CACNA1C
Nimodipine Pathway,SMP00380,hmdb,KCNIP2
Nimodipine Pathway,SMP00380,hmdb,CACNA1G
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMP00540,hmdb,ACADS
Sufentanil Pathway,SMP00417,hmdb,KCNIP2
Sufentanil Pathway,SMP00417,hmdb,CACNB1
Sufentanil Pathway,SMP00417,hmdb,ATP1A2
Non Ketotic Hyperglycinemia,SMP00223,hmdb,DMGDH
Labetalol Pathway,SMP00368,hmdb,ATP1A2
Labetalol Pathway,SMP00368,hmdb,KCNIP2
Labetalol Pathway,SMP00368,hmdb,CACNB1
Labetalol Pathway,SMP00368,hmdb,CACNA1G
Labetalol Pathway,SMP00368,hmdb,MYLK
Labetalol Pathway,SMP00368,hmdb,CACNA1C
Methylmalonic Aciduria,SMP00200,hmdb,ABAT
Methylmalonic Aciduria,SMP00200,hmdb,ACADS
Adenosine Deaminase Deficiency,SMP00144,hmdb,NT5C2
"Glycogenosis, Type III. Cori disease, Debrancher glycogenosis",SMP00553,hmdb,AMY1A
Propoxyphene Action Pathway,SMP00672,hmdb,CACNB1
Propoxyphene Action Pathway,SMP00672,hmdb,KCNIP2
Propoxyphene Action Pathway,SMP00672,hmdb,ATP1A2
Escitalopram Pathway,SMP00425,hmdb,KCNIP2
Escitalopram Pathway,SMP00425,hmdb,ATP1A2
Escitalopram Pathway,SMP00425,hmdb,CACNB1
Primary Hyperoxaluria Type I,SMP00352,hmdb,AARS2
Amiodarone Action Pathway,SMP00665,hmdb,KCNIP2
Amiodarone Action Pathway,SMP00665,hmdb,CACNA1C
Amiodarone Action Pathway,SMP00665,hmdb,CACNB1
Amiodarone Action Pathway,SMP00665,hmdb,CACNA1G
Amiodarone Action Pathway,SMP00665,hmdb,ATP1A2
Amiodarone Action Pathway,SMP00665,hmdb,MYLK
Isoprenaline Action Pathway,SMP00663,hmdb,ATP1A2
Isoprenaline Action Pathway,SMP00663,hmdb,CACNB1
Isoprenaline Action Pathway,SMP00663,hmdb,CACNA1C
Isoprenaline Action Pathway,SMP00663,hmdb,KCNIP2
Isoprenaline Action Pathway,SMP00663,hmdb,MYLK
Isoprenaline Action Pathway,SMP00663,hmdb,CACNA1G
Fatty acid Metabolism,SMP00051,hmdb,ACADS
Acebutolol Pathway,SMP00296,hmdb,MYLK
Acebutolol Pathway,SMP00296,hmdb,CACNA1G
Acebutolol Pathway,SMP00296,hmdb,KCNIP2
Acebutolol Pathway,SMP00296,hmdb,CACNA1C
Acebutolol Pathway,SMP00296,hmdb,CACNB1
Acebutolol Pathway,SMP00296,hmdb,ATP1A2
Molybdenum Cofactor Deficiency,SMP00203,hmdb,NT5C2
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMP00384,hmdb,ACADS
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMP00384,hmdb,ABAT
Diltiazem Pathway,SMP00359,hmdb,KCNIP2
Diltiazem Pathway,SMP00359,hmdb,CACNB1
Diltiazem Pathway,SMP00359,hmdb,ATP1A2
Diltiazem Pathway,SMP00359,hmdb,CACNA1C
Diltiazem Pathway,SMP00359,hmdb,MYLK
Diltiazem Pathway,SMP00359,hmdb,CACNA1G
Pindolol Pathway,SMP00306,hmdb,KCNIP2
Pindolol Pathway,SMP00306,hmdb,CACNA1G
Pindolol Pathway,SMP00306,hmdb,CACNB1
Pindolol Pathway,SMP00306,hmdb,MYLK
Pindolol Pathway,SMP00306,hmdb,ATP1A2
Pindolol Pathway,SMP00306,hmdb,CACNA1C
Nicotine Pathway,SMP00431,hmdb,KCNIP2
Nicotine Pathway,SMP00431,hmdb,CACNB1
Nicotine Pathway,SMP00431,hmdb,ATP1A2
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMP00202,hmdb,NT5C2
Docetaxel Pathway,SMP00435,hmdb,ABCB1
Irinotecan Pathway,SMP00433,hmdb,ABCB1
Ropivacaine Pathway,SMP00404,hmdb,ATP1A2
Ropivacaine Pathway,SMP00404,hmdb,KCNIP2
Ropivacaine Pathway,SMP00404,hmdb,CACNB1
Alprenolol Pathway,SMP00297,hmdb,KCNIP2
Alprenolol Pathway,SMP00297,hmdb,ATP1A2
Alprenolol Pathway,SMP00297,hmdb,CACNA1C
Alprenolol Pathway,SMP00297,hmdb,CACNA1G
Alprenolol Pathway,SMP00297,hmdb,CACNB1
Alprenolol Pathway,SMP00297,hmdb,MYLK
Morphine Pathway,SMP00406,hmdb,KCNIP2
Morphine Pathway,SMP00406,hmdb,CACNB1
Morphine Pathway,SMP00406,hmdb,ATP1A2
Adenylosuccinate Lyase Deficiency,SMP00167,hmdb,NT5C2
Gout or Kelley-Seegmiller Syndrome,SMP00365,hmdb,NT5C2
Naloxone Action Pathway,SMP00688,hmdb,CACNB1
Naloxone Action Pathway,SMP00688,hmdb,ATP1A2
Naloxone Action Pathway,SMP00688,hmdb,KCNIP2
Inositol Phosphate Metabolism,SMP00462,hmdb,INPP1
Inositol Phosphate Metabolism,SMP00462,hmdb,ISYNA1
Nateglinide Pathway,SMP00453,hmdb,CACNB1
Purine Metabolism,SMP00050,hmdb,NT5C2
Practolol Action Pathway,SMP00669,hmdb,MYLK
Practolol Action Pathway,SMP00669,hmdb,ATP1A2
Practolol Action Pathway,SMP00669,hmdb,CACNA1C
Practolol Action Pathway,SMP00669,hmdb,CACNB1
Practolol Action Pathway,SMP00669,hmdb,CACNA1G
Practolol Action Pathway,SMP00669,hmdb,KCNIP2
Sarcosinemia,SMP00244,hmdb,DMGDH
Etoposide Pathway,SMP00442,hmdb,ABCB1
Etoposide Pathway,SMP00442,hmdb,ABCC3
Methyclothiazide Pathway,SMP00081,hmdb,ATP1A2
Methyclothiazide Pathway,SMP00081,hmdb,SLC14A2
Starch and Sucrose Metabolism,SMP00058,hmdb,AMY1A
Cocaine Pathway,SMP00395,hmdb,CACNB1
Cocaine Pathway,SMP00395,hmdb,ATP1A2
Cocaine Pathway,SMP00395,hmdb,KCNIP2
Oxycodone Pathway,SMP00409,hmdb,CACNB1
Oxycodone Pathway,SMP00409,hmdb,ATP1A2
Oxycodone Pathway,SMP00409,hmdb,KCNIP2
Chlorothiazide Pathway,SMP00078,hmdb,ATP1A2
Chlorothiazide Pathway,SMP00078,hmdb,SLC14A2
Dimethylthiambutene Action Pathway,SMP00680,hmdb,CACNB1
Dimethylthiambutene Action Pathway,SMP00680,hmdb,KCNIP2
Dimethylthiambutene Action Pathway,SMP00680,hmdb,ATP1A2
Dimethylglycine Dehydrogenase Deficiency,SMP00484,hmdb,DMGDH
Etoposide Metabolism Pathway,SMP00601,hmdb,ABCB1
Etoposide Metabolism Pathway,SMP00601,hmdb,ABCC3
Ethylmalonic Encephalopathy,SMP00181,hmdb,ACADS
Betaxolol Pathway,SMP00299,hmdb,CACNA1G
Betaxolol Pathway,SMP00299,hmdb,KCNIP2
Betaxolol Pathway,SMP00299,hmdb,MYLK
Betaxolol Pathway,SMP00299,hmdb,CACNA1C
Betaxolol Pathway,SMP00299,hmdb,ATP1A2
Betaxolol Pathway,SMP00299,hmdb,CACNB1
Irinotecan Metabolism Pathway,SMP00600,hmdb,ABCB1
Levomethadyl Acetate Action Action Pathway,SMP00677,hmdb,KCNIP2
Levomethadyl Acetate Action Action Pathway,SMP00677,hmdb,CACNB1
Levomethadyl Acetate Action Action Pathway,SMP00677,hmdb,ATP1A2
Vinorelbine Pathway,SMP00439,hmdb,ABCB1
Vinorelbine Pathway,SMP00439,hmdb,ABCC3
Nitrendipine Pathway,SMP00382,hmdb,CACNA1C
Nitrendipine Pathway,SMP00382,hmdb,KCNIP2
Nitrendipine Pathway,SMP00382,hmdb,CACNA1G
Nitrendipine Pathway,SMP00382,hmdb,ATP1A2
Nitrendipine Pathway,SMP00382,hmdb,MYLK
Nitrendipine Pathway,SMP00382,hmdb,CACNB1
UMP Synthase Deiciency (Orotic Aciduria),SMP00219,hmdb,NT5C2
Mexiletine Pathway,SMP00329,hmdb,CACNA1C
Mexiletine Pathway,SMP00329,hmdb,MYLK
Mexiletine Pathway,SMP00329,hmdb,KCNIP2
Mexiletine Pathway,SMP00329,hmdb,ATP1A2
Mexiletine Pathway,SMP00329,hmdb,CACNA1G
Mexiletine Pathway,SMP00329,hmdb,CACNB1
3-Methylglutaconic Aciduria Type III,SMP00140,hmdb,ACADS
3-Methylglutaconic Aciduria Type III,SMP00140,hmdb,ABAT
Mycophenolic Acid Metabolism Pathway,SMP00652,hmdb,ABCB1
Familial lipoprotein lipase deficiency,SMP00530,hmdb,DGKA
Muscle/Heart Contraction,SMP00588,hmdb,CACNA1C
Muscle/Heart Contraction,SMP00588,hmdb,ATP1A2
Muscle/Heart Contraction,SMP00588,hmdb,CACNB1
Muscle/Heart Contraction,SMP00588,hmdb,MYLK
Muscle/Heart Contraction,SMP00588,hmdb,CACNA1G
Muscle/Heart Contraction,SMP00588,hmdb,KCNIP2
Ammonia Recycling,SMP00009,hmdb,ASNS
Dobutamine Action Pathway,SMP00662,hmdb,KCNIP2
Dobutamine Action Pathway,SMP00662,hmdb,MYLK
Dobutamine Action Pathway,SMP00662,hmdb,CACNA1G
Dobutamine Action Pathway,SMP00662,hmdb,ATP1A2
Dobutamine Action Pathway,SMP00662,hmdb,CACNB1
Dobutamine Action Pathway,SMP00662,hmdb,CACNA1C
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMP00542,hmdb,ACADS
Amiloride Pathway,SMP00133,hmdb,SLC14A2
Amiloride Pathway,SMP00133,hmdb,ATP1A2
3-hydroxyisobutyric aciduria,SMP00522,hmdb,ABAT
3-hydroxyisobutyric aciduria,SMP00522,hmdb,ACADS
Metoprolol Pathway,SMP00302,hmdb,KCNIP2
Metoprolol Pathway,SMP00302,hmdb,CACNA1C
Metoprolol Pathway,SMP00302,hmdb,ATP1A2
Metoprolol Pathway,SMP00302,hmdb,CACNA1G
Metoprolol Pathway,SMP00302,hmdb,MYLK
Metoprolol Pathway,SMP00302,hmdb,CACNB1
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMP00354,hmdb,MYLK
Pancreas Function,SMP00643,hmdb,CACNB1
Ketobemidone  Action Pathway,SMP00690,hmdb,CACNB1
Ketobemidone  Action Pathway,SMP00690,hmdb,KCNIP2
Ketobemidone  Action Pathway,SMP00690,hmdb,ATP1A2
Azathioprine Pathway,SMP00427,hmdb,NT5C2
Levobupivacaine Pathway,SMP00397,hmdb,ATP1A2
Levobupivacaine Pathway,SMP00397,hmdb,CACNB1
Levobupivacaine Pathway,SMP00397,hmdb,KCNIP2
Nebivolol Pathway,SMP00366,hmdb,CACNB1
Nebivolol Pathway,SMP00366,hmdb,CACNA1C
Nebivolol Pathway,SMP00366,hmdb,MYLK
Nebivolol Pathway,SMP00366,hmdb,KCNIP2
Nebivolol Pathway,SMP00366,hmdb,CACNA1G
Nebivolol Pathway,SMP00366,hmdb,ATP1A2
Prilocaine Pathway,SMP00401,hmdb,ATP1A2
Prilocaine Pathway,SMP00401,hmdb,KCNIP2
Prilocaine Pathway,SMP00401,hmdb,CACNB1
3-Methylthiofentanyl Action Pathway,SMP00679,hmdb,KCNIP2
3-Methylthiofentanyl Action Pathway,SMP00679,hmdb,ATP1A2
3-Methylthiofentanyl Action Pathway,SMP00679,hmdb,CACNB1
Cystinuria,SMP00723,hmdb,SLC14A2
Cystinuria,SMP00723,hmdb,ATP1A2
Hydrochlorothiazide Pathway,SMP00100,hmdb,SLC14A2
Hydrochlorothiazide Pathway,SMP00100,hmdb,ATP1A2
Disopyramide Pathway,SMP00325,hmdb,MYLK
Disopyramide Pathway,SMP00325,hmdb,ATP1A2
Disopyramide Pathway,SMP00325,hmdb,CACNB1
Disopyramide Pathway,SMP00325,hmdb,KCNIP2
Disopyramide Pathway,SMP00325,hmdb,CACNA1C
Disopyramide Pathway,SMP00325,hmdb,CACNA1G
Glutaric Aciduria Type I,SMP00185,hmdb,ACADS
Xanthinuria type II,SMP00513,hmdb,NT5C2
Arbutamine Action Pathway,SMP00664,hmdb,CACNA1G
Arbutamine Action Pathway,SMP00664,hmdb,MYLK
Arbutamine Action Pathway,SMP00664,hmdb,ATP1A2
Arbutamine Action Pathway,SMP00664,hmdb,CACNA1C
Arbutamine Action Pathway,SMP00664,hmdb,KCNIP2
Arbutamine Action Pathway,SMP00664,hmdb,CACNB1
Lamivudine Metabolism Pathway,SMP00649,hmdb,ABCC3
Lamivudine Metabolism Pathway,SMP00649,hmdb,ABCB1
5-oxoprolinase deficiency,SMP00500,hmdb,ANPEP
Mercaptopurine Pathway,SMP00428,hmdb,NT5C2
Xanthinuria type I,SMP00512,hmdb,NT5C2
Metolazone Pathway,SMP00105,hmdb,ATP1A2
Metolazone Pathway,SMP00105,hmdb,SLC14A2
Hydrocodone Pathway,SMP00411,hmdb,ATP1A2
Hydrocodone Pathway,SMP00411,hmdb,CACNB1
Hydrocodone Pathway,SMP00411,hmdb,KCNIP2
AICA-Ribosiduria,SMP00168,hmdb,NT5C2
sarcosine oncometabolite pathway ,SMP02313,hmdb,DMGDH
Sucrase-isomaltase deficiency,SMP00557,hmdb,AMY1A
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMP00138,hmdb,ACADS
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMP00138,hmdb,ABAT
Malonic Aciduria,SMP00198,hmdb,ABAT
Propranolol Pathway,SMP00307,hmdb,ATP1A2
Propranolol Pathway,SMP00307,hmdb,KCNIP2
Propranolol Pathway,SMP00307,hmdb,CACNA1G
Propranolol Pathway,SMP00307,hmdb,CACNA1C
Propranolol Pathway,SMP00307,hmdb,MYLK
Propranolol Pathway,SMP00307,hmdb,CACNB1
Glycine and Serine Metabolism,SMP00004,hmdb,DMGDH
Carvedilol Pathway,SMP00367,hmdb,ATP1A2
Carvedilol Pathway,SMP00367,hmdb,MYLK
Carvedilol Pathway,SMP00367,hmdb,CACNA1G
Carvedilol Pathway,SMP00367,hmdb,CACNB1
Carvedilol Pathway,SMP00367,hmdb,CACNA1C
Carvedilol Pathway,SMP00367,hmdb,KCNIP2
Nicotinate and Nicotinamide Metabolism,SMP00048,hmdb,NT5C2
Isovaleric Aciduria,SMP00238,hmdb,ABAT
Isovaleric Aciduria,SMP00238,hmdb,ACADS
Chlorthalidone Pathway,SMP00122,hmdb,SLC14A2
Chlorthalidone Pathway,SMP00122,hmdb,ATP1A2
Glycogen synthetase deficiency,SMP00552,hmdb,AMY1A
Tocainide Pathway,SMP00330,hmdb,CACNA1G
Tocainide Pathway,SMP00330,hmdb,CACNA1C
Tocainide Pathway,SMP00330,hmdb,MYLK
Tocainide Pathway,SMP00330,hmdb,CACNB1
Tocainide Pathway,SMP00330,hmdb,KCNIP2
Tocainide Pathway,SMP00330,hmdb,ATP1A2
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,CACNB1
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,CACNA1C
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,CACNA1G
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,ATP1A2
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,KCNIP2
Fosphenytoin (Antiarrhythmic) Pathway,SMP00326,hmdb,MYLK
Heroin Pathway,SMP00407,hmdb,CACNB1
Heroin Pathway,SMP00407,hmdb,KCNIP2
Heroin Pathway,SMP00407,hmdb,ATP1A2
Flecainide Pathway,SMP00331,hmdb,KCNIP2
Flecainide Pathway,SMP00331,hmdb,CACNB1
Flecainide Pathway,SMP00331,hmdb,ATP1A2
Flecainide Pathway,SMP00331,hmdb,CACNA1G
Flecainide Pathway,SMP00331,hmdb,MYLK
Flecainide Pathway,SMP00331,hmdb,CACNA1C
3-Phosphoglycerate dehydrogenase deficiency,SMP00721,hmdb,DMGDH
Imipramine Pathway,SMP00422,hmdb,ATP1A2
Imipramine Pathway,SMP00422,hmdb,KCNIP2
Imipramine Pathway,SMP00422,hmdb,CACNB1
Homocarnosinosis,SMP00385,hmdb,ABAT
Epinephrine Action Pathway,SMP00661,hmdb,KCNIP2
Epinephrine Action Pathway,SMP00661,hmdb,CACNB1
Epinephrine Action Pathway,SMP00661,hmdb,CACNA1G
Epinephrine Action Pathway,SMP00661,hmdb,ATP1A2
Epinephrine Action Pathway,SMP00661,hmdb,CACNA1C
Epinephrine Action Pathway,SMP00661,hmdb,MYLK
Glycerol Kinase Deficiency,SMP00187,hmdb,DGKA
Desipramine Pathway,SMP00423,hmdb,CACNB1
Desipramine Pathway,SMP00423,hmdb,ATP1A2
Desipramine Pathway,SMP00423,hmdb,KCNIP2
Vitamin A Deficiency,SMP00336,hmdb,DHRS3
Vitamin A Deficiency,SMP00336,hmdb,ALDH1A2
Glycerolipid Metabolism,SMP00039,hmdb,DGKA
Carnitine palmitoyl transferase deficiency (II),SMP00541,hmdb,ACADS
Clopidogrel Metabolism Pathway,SMP00610,hmdb,ABCB1
Carnitine palmitoyl transferase deficiency (I),SMP00538,hmdb,ACADS
Trichlormethiazide Pathway,SMP00121,hmdb,ATP1A2
Trichlormethiazide Pathway,SMP00121,hmdb,SLC14A2
Pentazocine Action Pathway,SMP00686,hmdb,KCNIP2
Pentazocine Action Pathway,SMP00686,hmdb,CACNB1
Pentazocine Action Pathway,SMP00686,hmdb,ATP1A2
"Valine, Leucine and Isoleucine Degradation",SMP00032,hmdb,ACADS
"Valine, Leucine and Isoleucine Degradation",SMP00032,hmdb,ABAT
Phospholipid Biosynthesis,SMP00025,hmdb,DGKA
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMP00179,hmdb,DMGDH
Retinol Metabolism,SMP00074,hmdb,DHRS3
Retinol Metabolism,SMP00074,hmdb,ALDH1A2
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,CACNB1
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,CACNA1G
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,MYLK
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,ATP1A2
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,KCNIP2
Lidocaine (Antiarrhythmic) Pathway,SMP00328,hmdb,CACNA1C
Alfentanil Pathway,SMP00413,hmdb,KCNIP2
Alfentanil Pathway,SMP00413,hmdb,CACNB1
Alfentanil Pathway,SMP00413,hmdb,ATP1A2
Clopidogrel Pathway,SMP00260,hmdb,ABCB1
Ethacrynic Acid pathway,SMP00097,hmdb,ATP1A2
Ethacrynic Acid pathway,SMP00097,hmdb,SLC14A2
Quinethazone Pathway,SMP00091,hmdb,ATP1A2
Quinethazone Pathway,SMP00091,hmdb,SLC14A2
Naltrexone Action Pathway,SMP00687,hmdb,KCNIP2
Naltrexone Action Pathway,SMP00687,hmdb,CACNB1
Naltrexone Action Pathway,SMP00687,hmdb,ATP1A2
Beta-Alanine Metabolism,SMP00007,hmdb,ABAT
Isradipine Pathway,SMP00378,hmdb,ATP1A2
Isradipine Pathway,SMP00378,hmdb,CACNB1
Isradipine Pathway,SMP00378,hmdb,CACNA1G
Isradipine Pathway,SMP00378,hmdb,KCNIP2
Isradipine Pathway,SMP00378,hmdb,MYLK
Isradipine Pathway,SMP00378,hmdb,CACNA1C
Triamterene Pathway,SMP00132,hmdb,ATP1A2
Triamterene Pathway,SMP00132,hmdb,SLC14A2
Proparacaine Pathway,SMP00403,hmdb,ATP1A2
Proparacaine Pathway,SMP00403,hmdb,CACNB1
Proparacaine Pathway,SMP00403,hmdb,KCNIP2
Lactose Degradation,SMP00457,hmdb,ATP1A2
Lysinuric Protein Intolerance,SMP00197,hmdb,SLC14A2
Lysinuric Protein Intolerance,SMP00197,hmdb,ATP1A2
Glutathione Metabolism,SMP00015,hmdb,ANPEP
Canavan Disease,SMP00175,hmdb,ASNS
Canavan Disease,SMP00175,hmdb,ABAT
Penbutolol Pathway,SMP00305,hmdb,CACNA1C
Penbutolol Pathway,SMP00305,hmdb,CACNB1
Penbutolol Pathway,SMP00305,hmdb,CACNA1G
Penbutolol Pathway,SMP00305,hmdb,ATP1A2
Penbutolol Pathway,SMP00305,hmdb,MYLK
Penbutolol Pathway,SMP00305,hmdb,KCNIP2
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,CACNA1C
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,KCNIP2
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,ATP1A2
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,MYLK
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,CACNA1G
Procainamide (Antiarrhythmic) Pathway,SMP00324,hmdb,CACNB1
Polythiazide Pathway,SMP00080,hmdb,ATP1A2
Polythiazide Pathway,SMP00080,hmdb,SLC14A2
Acetaminophen Metabolism Pathway,SMP00640,hmdb,ABCB1
Pyruvate Carboxylase Deficiency,SMP00350,hmdb,AARS2
Succinic semialdehyde dehydrogenase deficiency,SMP00567,hmdb,ABAT
Glibenclamide Pathway,SMP00460,hmdb,CACNB1
Esmolol Pathway,SMP00301,hmdb,MYLK
Esmolol Pathway,SMP00301,hmdb,CACNA1C
Esmolol Pathway,SMP00301,hmdb,ATP1A2
Esmolol Pathway,SMP00301,hmdb,CACNA1G
Esmolol Pathway,SMP00301,hmdb,KCNIP2
Esmolol Pathway,SMP00301,hmdb,CACNB1
Mucopolysaccharidosis VI. Sly syndrome,SMP00556,hmdb,AMY1A
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMP00137,hmdb,ABAT
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMP00137,hmdb,ACADS
Malonyl-coa decarboxylase deficiency,SMP00502,hmdb,ABAT
Hydromorphone Pathway,SMP00410,hmdb,ATP1A2
Hydromorphone Pathway,SMP00410,hmdb,KCNIP2
Hydromorphone Pathway,SMP00410,hmdb,CACNB1
Dezocine Action Pathway,SMP00676,hmdb,KCNIP2
Dezocine Action Pathway,SMP00676,hmdb,CACNB1
Dezocine Action Pathway,SMP00676,hmdb,ATP1A2
Trifunctional protein deficiency,SMP00545,hmdb,ACADS
Gamma-Glutamyltransferase Deficiency,SMP00183,hmdb,ANPEP
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMP00237,hmdb,ABAT
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMP00237,hmdb,ACADS
Isobutyryl-coa dehydrogenase deficiency,SMP00523,hmdb,ACADS
Isobutyryl-coa dehydrogenase deficiency,SMP00523,hmdb,ABAT
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMP00539,hmdb,ACADS
Indapamide Pathway,SMP00110,hmdb,SLC14A2
Indapamide Pathway,SMP00110,hmdb,ATP1A2
Iminoglycinuria,SMP00193,hmdb,ATP1A2
Iminoglycinuria,SMP00193,hmdb,SLC14A2
Diphenoxylate Action Pathway,SMP00675,hmdb,KCNIP2
Diphenoxylate Action Pathway,SMP00675,hmdb,ATP1A2
Diphenoxylate Action Pathway,SMP00675,hmdb,CACNB1
Timolol Action Pathway,SMP00659,hmdb,CACNA1C
Timolol Action Pathway,SMP00659,hmdb,CACNA1G
Timolol Action Pathway,SMP00659,hmdb,CACNB1
Timolol Action Pathway,SMP00659,hmdb,MYLK
Timolol Action Pathway,SMP00659,hmdb,KCNIP2
Timolol Action Pathway,SMP00659,hmdb,ATP1A2
Vinblastine Pathway,SMP00436,hmdb,ABCC3
Vinblastine Pathway,SMP00436,hmdb,ABCB1
3-Methylglutaconic Aciduria Type I,SMP00139,hmdb,ACADS
3-Methylglutaconic Aciduria Type I,SMP00139,hmdb,ABAT
Carteolol Action Pathway,SMP00658,hmdb,CACNB1
Carteolol Action Pathway,SMP00658,hmdb,CACNA1C
Carteolol Action Pathway,SMP00658,hmdb,ATP1A2
Carteolol Action Pathway,SMP00658,hmdb,KCNIP2
Carteolol Action Pathway,SMP00658,hmdb,CACNA1G
Carteolol Action Pathway,SMP00658,hmdb,MYLK
Glucose Transporter Defect (SGLT2),SMP00245,hmdb,SLC14A2
Glucose Transporter Defect (SGLT2),SMP00245,hmdb,ATP1A2
Blue diaper syndrome,SMP00583,hmdb,SLC14A2
Blue diaper syndrome,SMP00583,hmdb,ATP1A2
Quinidine Pathway,SMP00323,hmdb,CACNA1G
Quinidine Pathway,SMP00323,hmdb,KCNIP2
Quinidine Pathway,SMP00323,hmdb,CACNA1C
Quinidine Pathway,SMP00323,hmdb,CACNB1
Quinidine Pathway,SMP00323,hmdb,ATP1A2
Quinidine Pathway,SMP00323,hmdb,MYLK
Propanoate Metabolism,SMP00016,hmdb,ABAT
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,MYLK
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,CACNA1G
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,CACNB1
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,CACNA1C
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,KCNIP2
Phenytoin (Antiarrhythmic) Pathway,SMP00327,hmdb,ATP1A2
Nuclear Receptors in Lipid Metabolism and Toxicity,WP299,wiki,ABCC3
Nuclear Receptors in Lipid Metabolism and Toxicity,WP299,wiki,ABCB1
Fatty Acid Beta Oxidation,WP143,wiki,PNPLA2
Fatty Acid Beta Oxidation,WP143,wiki,ACADS
Fatty Acid Beta Oxidation,WP143,wiki,LIPE
Inflammatory Response Pathway,WP453,wiki,IL4R
Prostaglandin Synthesis and Regulation,WP98,wiki,PTGER3
Small Ligand GPCRs,WP247,wiki,PTGER3
Bladder Cancer,WP2828,wiki,CDK4
Matrix Metalloproteinases,WP129,wiki,MMP16
Physiological and Pathological Hypertrophy  of the Heart,WP1528,wiki,LIFR
"GPCRs, Class A Rhodopsin-like",WP455,wiki,OR2A4
"GPCRs, Class A Rhodopsin-like",WP455,wiki,PTGER3
"GPCRs, Class A Rhodopsin-like",WP455,wiki,ADRA2A
"GPCRs, Class A Rhodopsin-like",WP455,wiki,GPR63
"GPCRs, Class A Rhodopsin-like",WP455,wiki,F2R
"GPCRs, Class A Rhodopsin-like",WP455,wiki,GRPR
"GPCRs, Class A Rhodopsin-like",WP455,wiki,OXTR
Pathogenic Escherichia coli infection,WP2272,wiki,TUBA4A
Pathogenic Escherichia coli infection,WP2272,wiki,YWHAQ
Wnt Signaling Pathway and Pluripotency,WP399,wiki,LRP6
mRNA Processing,WP411,wiki,NXF1
mRNA Processing,WP411,wiki,SF3B3
mRNA Processing,WP411,wiki,SNRPN
mRNA Processing,WP411,wiki,PRPF4B
IL17 signaling pathway,WP2112,wiki,IL17RD
DNA Damage Response (only ATM dependent),WP710,wiki,PIK3C2G
Vitamin A and Carotenoid Metabolism,WP716,wiki,DHRS3
Vitamin A and Carotenoid Metabolism,WP716,wiki,ALDH1A2
Drug Induction of Bile Acid Pathway,WP2289,wiki,ABCC3
Drug Induction of Bile Acid Pathway,WP2289,wiki,ABCB1
Calcium Regulation in the Cardiac Cell,WP536,wiki,YWHAQ
Calcium Regulation in the Cardiac Cell,WP536,wiki,CACNA1C
Calcium Regulation in the Cardiac Cell,WP536,wiki,CAMK1
Calcium Regulation in the Cardiac Cell,WP536,wiki,GNG7
Calcium Regulation in the Cardiac Cell,WP536,wiki,CASQ2
Calcium Regulation in the Cardiac Cell,WP536,wiki,GNB5
Calcium Regulation in the Cardiac Cell,WP536,wiki,CACNB1
Peptide GPCRs,WP24,wiki,GRPR
Peptide GPCRs,WP24,wiki,OXTR
ErbB Signaling Pathway,WP673,wiki,NRG1
ErbB Signaling Pathway,WP673,wiki,EGF
Circadian rythm related genes,WP3594,wiki,NPAS2
Circadian rythm related genes,WP3594,wiki,KCNMA1
Circadian rythm related genes,WP3594,wiki,NGFR
Circadian rythm related genes,WP3594,wiki,CRY2
Circadian rythm related genes,WP3594,wiki,CRY1
Circadian rythm related genes,WP3594,wiki,PROK1
Circadian rythm related genes,WP3594,wiki,CDK4
Circadian rythm related genes,WP3594,wiki,BHLHE40
Circadian rythm related genes,WP3594,wiki,PER2
Heart Development,WP1591,wiki,BHLHE40
Heart Development,WP1591,wiki,SMYD1
Senescence and Autophagy in Cancer,WP615,wiki,IGF1R
Extracellular vesicle-mediated signaling in recipient cells,WP2870,wiki,TGFB2
Monoamine GPCRs,WP58,wiki,ADRA2A
Focal Adhesion,WP306,wiki,PAK3
Focal Adhesion,WP306,wiki,PDGFA
Focal Adhesion,WP306,wiki,ITGA3
Focal Adhesion,WP306,wiki,EGF
Focal Adhesion,WP306,wiki,ACTN1
Focal Adhesion,WP306,wiki,LAMA1
Focal Adhesion,WP306,wiki,COL4A6
Focal Adhesion,WP306,wiki,TNC
Focal Adhesion,WP306,wiki,RELN
Focal Adhesion,WP306,wiki,MYLK
Focal Adhesion,WP306,wiki,IGF1R
Glycolysis and Gluconeogenesis,WP534,wiki,PFKP
Monoamine Transport,WP727,wiki,TNFRSF11B
Constitutive Androstane Receptor Pathway,WP2875,wiki,ABCC3
Constitutive Androstane Receptor Pathway,WP2875,wiki,ABCB1
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,DES
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,CACNB1
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,ITGA3
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,ACTN1
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,CACNA1C
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,CACNA2D1
Arrhythmogenic Right Ventricular Cardiomyopathy,WP2118,wiki,CACNB2
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,WP3612,wiki,ABCC3
G1 to S cell cycle control,WP45,wiki,CDK4
G13 Signaling Pathway,WP524,wiki,PAK3
Apoptosis,WP254,wiki,TP63
Apoptosis,WP254,wiki,IGF1R
Apoptosis,WP254,wiki,HELLS
Apoptosis,WP254,wiki,TNFRSF10B
Wnt Signaling Pathway,WP428,wiki,ROR2
Wnt Signaling Pathway,WP428,wiki,LRP6
Mitochondrial LC-Fatty Acid Beta-Oxidation,WP368,wiki,ACADS
Complement Activation,WP545,wiki,C4A
Corticotropin-releasing hormone signaling pathway,WP2355,wiki,KRT14
Corticotropin-releasing hormone signaling pathway,WP2355,wiki,TBX19
Corticotropin-releasing hormone signaling pathway,WP2355,wiki,FOSB
Corticotropin-releasing hormone signaling pathway,WP2355,wiki,GNB5
Exercise-induced Circadian Regulation,WP410,wiki,CRY2
Exercise-induced Circadian Regulation,WP410,wiki,CRY1
Exercise-induced Circadian Regulation,WP410,wiki,PER2
TGF-beta Receptor Signaling,WP560,wiki,EGF
TGF-beta Receptor Signaling,WP560,wiki,LIF
p38 MAPK Signaling Pathway,WP400,wiki,TGFB2
Retinoblastoma (RB) in Cancer,WP2446,wiki,CDK4
IL1 and megakaryocytes in obesity,WP2865,wiki,F2R
Interleukin-11 Signaling Pathway,WP2332,wiki,PIAS1
Endochondral Ossification,WP474,wiki,GLI3
Endochondral Ossification,WP474,wiki,FRZB
Endochondral Ossification,WP474,wiki,IGF1R
Endochondral Ossification,WP474,wiki,TGFB2
Photodynamic therapy-induced unfolded protein response,WP3613,wiki,ASNS
Cytokines and Inflammatory Response,WP530,wiki,PDGFA
Endoderm Differentiation,WP2853,wiki,SLC2A12
Endoderm Differentiation,WP2853,wiki,PIAS1
Endoderm Differentiation,WP2853,wiki,GLI2
Endoderm Differentiation,WP2853,wiki,ATP8B2
Insulin Signaling,WP481,wiki,EHD2
Insulin Signaling,WP481,wiki,MAP3K12
Insulin Signaling,WP481,wiki,RHOJ
Insulin Signaling,WP481,wiki,IGF1R
Insulin Signaling,WP481,wiki,PIK3C2G
Insulin Signaling,WP481,wiki,LIPE
MAPK Signaling Pathway,WP382,wiki,EGF
MAPK Signaling Pathway,WP382,wiki,TGFB2
MAPK Signaling Pathway,WP382,wiki,DUSP5
MAPK Signaling Pathway,WP382,wiki,MAP3K12
Glycogen Metabolism,WP500,wiki,PHKG2
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,WP706,wiki,C4A
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,WP706,wiki,VIPR2
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,WP706,wiki,YWHAQ
Glutathione metabolism,WP100,wiki,ANPEP
Codeine and Morphine Metabolism,WP1604,wiki,ABCC3
Codeine and Morphine Metabolism,WP1604,wiki,ABCB1
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,EGF
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,LRP6
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,LIF
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,IGF1R
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,MYLK
MicroRNAs in cardiomyocyte hypertrophy,WP1544,wiki,NRG1
Angiopoietin Like Protein 8 Regulatory Pathway,WP3915,wiki,MAP3K12
Angiopoietin Like Protein 8 Regulatory Pathway,WP3915,wiki,PIK3C2G
Fluoropyrimidine Activity,WP1601,wiki,ABCC3
Parkin-Ubiquitin Proteasomal System pathway,WP2359,wiki,TUBA4A
Striated Muscle Contraction,WP383,wiki,TPM4
Striated Muscle Contraction,WP383,wiki,ACTA2
Striated Muscle Contraction,WP383,wiki,DES
Cell Cycle,WP179,wiki,YWHAQ
Cell Cycle,WP179,wiki,CDC14A
Cell Cycle,WP179,wiki,CDK4
TP53 Network,WP1742,wiki,TP63
Integrin-mediated Cell Adhesion,WP185,wiki,PAK3
Integrin-mediated Cell Adhesion,WP185,wiki,TNS1
Integrin-mediated Cell Adhesion,WP185,wiki,CAPN5
Integrin-mediated Cell Adhesion,WP185,wiki,ITGA3
PDGF Pathway,WP2526,wiki,PDGFA
Triacylglyceride Synthesis,WP325,wiki,LIPE
Triacylglyceride Synthesis,WP325,wiki,PNPLA2
Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,wiki,TNFRSF10B
Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,wiki,IER3
Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,wiki,F2R
Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,wiki,NRG1
Apoptosis-related network due to altered Notch3 in ovarian cancer,WP2864,wiki,HELLS
Hypertrophy Model,WP516,wiki,NR4A3
"GPCRs, Other",WP117,wiki,F2R
"GPCRs, Other",WP117,wiki,GRPR
"GPCRs, Other",WP117,wiki,OR2A4
Ectoderm Differentiation,WP2858,wiki,FHL2
Ovarian Infertility Genes,WP34,wiki,CDK4
Complement and Coagulation Cascades,WP558,wiki,CFI
Complement and Coagulation Cascades,WP558,wiki,THBD
Complement and Coagulation Cascades,WP558,wiki,F2R
Tryptophan metabolism,WP465,wiki,ALDH1A2
T-Cell Receptor and Co-stimulatory Signaling,WP2583,wiki,CSNK1A1
Allograft Rejection,WP2328,wiki,C4A
Allograft Rejection,WP2328,wiki,C4a
Interferon type I signaling pathways,WP585,wiki,PIAS1
Adipogenesis,WP236,wiki,LIFR
Adipogenesis,WP236,wiki,LIF
Adipogenesis,WP236,wiki,FRZB
Adipogenesis,WP236,wiki,LIPE
Myometrial Relaxation and Contraction Pathways,WP289,wiki,MAFF
Myometrial Relaxation and Contraction Pathways,WP289,wiki,OXTR
Myometrial Relaxation and Contraction Pathways,WP289,wiki,IGFBP4
Myometrial Relaxation and Contraction Pathways,WP289,wiki,GNB5
Myometrial Relaxation and Contraction Pathways,WP289,wiki,ACTA2
Myometrial Relaxation and Contraction Pathways,WP289,wiki,YWHAQ
Myometrial Relaxation and Contraction Pathways,WP289,wiki,CNN1
Myometrial Relaxation and Contraction Pathways,WP289,wiki,GNG7
Human Thyroid Stimulating Hormone (TSH) signaling pathway,WP2032,wiki,CDK4
Human Thyroid Stimulating Hormone (TSH) signaling pathway,WP2032,wiki,IGF1R
Eukaryotic Transcription Initiation,WP405,wiki,POLR1B
G Protein Signaling Pathways,WP35,wiki,GNG7
G Protein Signaling Pathways,WP35,wiki,GNB5
G Protein Signaling Pathways,WP35,wiki,SLC9A1
"GPCRs, Class B Secretin-like",WP334,wiki,VIPR2
Alanine and aspartate metabolism,WP106,wiki,ABAT
Regulation of Actin Cytoskeleton,WP51,wiki,MYLK
Regulation of Actin Cytoskeleton,WP51,wiki,PDGFA
Regulation of Actin Cytoskeleton,WP51,wiki,PAK3
Regulation of Actin Cytoskeleton,WP51,wiki,SLC9A1
Regulation of Actin Cytoskeleton,WP51,wiki,F2R
Regulation of Actin Cytoskeleton,WP51,wiki,PIP5K1A
Regulation of Actin Cytoskeleton,WP51,wiki,ACTN1
Regulation of Actin Cytoskeleton,WP51,wiki,EGF
Regulation of Actin Cytoskeleton,WP51,wiki,PIK3C2G
MAPK Cascade,WP422,wiki,MAP3K12
Nicotine Activity on Chromaffin Cells,WP1603,wiki,CACNA1G
Nicotine Activity on Chromaffin Cells,WP1603,wiki,CACNA1C
Activation of C3 and C5,R-HSA-174577,reactome,C4A
Signalling to ERKs,R-HSA-187687,reactome,EGF
Signalling to ERKs,R-HSA-187687,reactome,DLG4
Signalling to ERKs,R-HSA-187687,reactome,DUSP5
Signalling to ERKs,R-HSA-187687,reactome,NRG1
Signalling to ERKs,R-HSA-187687,reactome,IL17RD
Signalling to ERKs,R-HSA-187687,reactome,DUSP16
Signal Transduction,R-HSA-162582,reactome,OXTR
Signal Transduction,R-HSA-162582,reactome,PROK1
Signal Transduction,R-HSA-162582,reactome,RHOJ
Signal Transduction,R-HSA-162582,reactome,LPPR2
Signal Transduction,R-HSA-162582,reactome,TNFRSF10B
Signal Transduction,R-HSA-162582,reactome,ALDH1A2
Signal Transduction,R-HSA-162582,reactome,DUSP16
Signal Transduction,R-HSA-162582,reactome,EGF
Signal Transduction,R-HSA-162582,reactome,OR2A4
Signal Transduction,R-HSA-162582,reactome,LRP6
Signal Transduction,R-HSA-162582,reactome,GNG7
Signal Transduction,R-HSA-162582,reactome,ITGA3
Signal Transduction,R-HSA-162582,reactome,LAMA1
Signal Transduction,R-HSA-162582,reactome,AXL
Signal Transduction,R-HSA-162582,reactome,RCVRN
Signal Transduction,R-HSA-162582,reactome,NGFR
Signal Transduction,R-HSA-162582,reactome,GLI2
Signal Transduction,R-HSA-162582,reactome,GLI3
Signal Transduction,R-HSA-162582,reactome,NRG1
Signal Transduction,R-HSA-162582,reactome,ADRA2A
Signal Transduction,R-HSA-162582,reactome,IER3
Signal Transduction,R-HSA-162582,reactome,PIP5K1A
Signal Transduction,R-HSA-162582,reactome,CDK4
Signal Transduction,R-HSA-162582,reactome,PLCB4
Signal Transduction,R-HSA-162582,reactome,PTGER3
Signal Transduction,R-HSA-162582,reactome,PAK3
Signal Transduction,R-HSA-162582,reactome,GNB5
Signal Transduction,R-HSA-162582,reactome,MYLK
Signal Transduction,R-HSA-162582,reactome,SMURF2
Signal Transduction,R-HSA-162582,reactome,DHRS3
Signal Transduction,R-HSA-162582,reactome,CDC14A
Signal Transduction,R-HSA-162582,reactome,VIPR2
Signal Transduction,R-HSA-162582,reactome,YWHAQ
Signal Transduction,R-HSA-162582,reactome,ROR2
Signal Transduction,R-HSA-162582,reactome,IL17RD
Signal Transduction,R-HSA-162582,reactome,F2R
Signal Transduction,R-HSA-162582,reactome,GRPR
Signal Transduction,R-HSA-162582,reactome,DUSP5
Signal Transduction,R-HSA-162582,reactome,DLG4
Signal Transduction,R-HSA-162582,reactome,IGF1R
Signal Transduction,R-HSA-162582,reactome,DGKA
Signal Transduction,R-HSA-162582,reactome,TUBA4A
Triglyceride metabolism,R-HSA-8979227,reactome,LIPE
Generation of second messenger molecules,R-HSA-202433,reactome,PAK3
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,DUSP5
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,IGF1R
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,NRG1
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,DLG4
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,EGF
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,DUSP16
IRS-related events triggered by IGF1R,R-HSA-2428928,reactome,IL17RD
Collagen degradation,R-HSA-1442490,reactome,COL4A6
Vasopressin-like receptors,R-HSA-388479,reactome,OXTR
The role of GTSE1 in G2/M progression after G2 checkpoint,R-HSA-8852276,reactome,TUBA4A
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",R-HSA-168643,reactome,IRAK2
G beta:gamma signalling through PLC beta,R-HSA-418217,reactome,GNG7
G beta:gamma signalling through PLC beta,R-HSA-418217,reactome,GNB5
"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397,reactome,SLCO2A1
Protein ubiquitination,R-HSA-8852135,reactome,UBE2Z
HSP90 chaperone cycle for steroid hormone receptors (SHR),R-HSA-3371497,reactome,TUBA4A
MAP2K and MAPK activation,R-HSA-5674135,reactome,IL17RD
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426,reactome,TNC
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426,reactome,PNPLA2
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426,reactome,IGFBP4
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426,reactome,STC2
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426,reactome,C4A
Glucagon signaling in metabolic regulation,R-HSA-163359,reactome,GNG7
Collagen biosynthesis and modifying enzymes,R-HSA-1650814,reactome,LEPREL1
Collagen biosynthesis and modifying enzymes,R-HSA-1650814,reactome,COL4A6
Interleukin-2 family signaling,R-HSA-451927,reactome,DLG4
Interleukin-2 family signaling,R-HSA-451927,reactome,NRG1
Interleukin-2 family signaling,R-HSA-451927,reactome,DUSP16
Interleukin-2 family signaling,R-HSA-451927,reactome,DUSP5
Interleukin-2 family signaling,R-HSA-451927,reactome,IL17RD
Interleukin-2 family signaling,R-HSA-451927,reactome,EGF
Cyclin E associated events during G1/S transition ,R-HSA-69202,reactome,CDK4
Intraflagellar transport,R-HSA-5620924,reactome,TUBA4A
Trafficking of AMPA receptors,R-HSA-399719,reactome,GRIA4
Trafficking of AMPA receptors,R-HSA-399719,reactome,DLG4
G alpha (q) signalling events,R-HSA-416476,reactome,F2R
G alpha (q) signalling events,R-HSA-416476,reactome,GNB5
G alpha (q) signalling events,R-HSA-416476,reactome,GNG7
G alpha (q) signalling events,R-HSA-416476,reactome,GRPR
G alpha (q) signalling events,R-HSA-416476,reactome,OXTR
G alpha (q) signalling events,R-HSA-416476,reactome,PROK1
G alpha (q) signalling events,R-HSA-416476,reactome,PLCB4
G alpha (q) signalling events,R-HSA-416476,reactome,DGKA
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC7A1
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC44A1
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC2A12
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC9A1
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC14A2
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC22A4
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLC17A7
SLC-mediated transmembrane transport,R-HSA-425407,reactome,SLCO2A1
Antiviral mechanism by IFN-stimulated genes,R-HSA-1169410,reactome,EIF4A3
Mitotic Prometaphase,R-HSA-68877,reactome,TUBA4A
Platelet degranulation ,R-HSA-114608,reactome,EGF
Platelet degranulation ,R-HSA-114608,reactome,TUBA4A
Platelet degranulation ,R-HSA-114608,reactome,TGFB2
Platelet degranulation ,R-HSA-114608,reactome,ACTN1
Unfolded Protein Response (UPR),R-HSA-381119,reactome,ASNS
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,DLG4
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,NRG1
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,DUSP5
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,DUSP16
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,IL17RD
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988,reactome,EGF
Mitotic G1-G1/S phases,R-HSA-453279,reactome,CDK4
Membrane Trafficking,R-HSA-199991,reactome,TUBA4A
Membrane Trafficking,R-HSA-199991,reactome,YWHAQ
Membrane Trafficking,R-HSA-199991,reactome,EGF
"Inactivation, recovery and regulation of the phototransduction cascade",R-HSA-2514859,reactome,RCVRN
Choline catabolism,R-HSA-6798163,reactome,DMGDH
Choline catabolism,R-HSA-6798163,reactome,SLC44A1
MET promotes cell motility,R-HSA-8875878,reactome,LAMA1
MET promotes cell motility,R-HSA-8875878,reactome,ITGA3
mRNA Splicing,R-HSA-72172,reactome,SF3B3
mRNA Splicing,R-HSA-72172,reactome,EIF4A3
Peptide ligand-binding receptors,R-HSA-375276,reactome,OXTR
Peptide ligand-binding receptors,R-HSA-375276,reactome,GRPR
Peptide ligand-binding receptors,R-HSA-375276,reactome,PROK1
Peptide ligand-binding receptors,R-HSA-375276,reactome,F2R
Recycling pathway of L1,R-HSA-437239,reactome,TUBA4A
The phototransduction cascade,R-HSA-2514856,reactome,RCVRN
Signaling by Wnt,R-HSA-195721,reactome,LRP6
Signaling by Wnt,R-HSA-195721,reactome,GNG7
Signaling by Wnt,R-HSA-195721,reactome,GNB5
Signaling by Wnt,R-HSA-195721,reactome,SMURF2
Signaling by Wnt,R-HSA-195721,reactome,ROR2
Sema3A PAK dependent Axon repulsion,R-HSA-399954,reactome,PAK3
Constitutive Signaling by EGFRvIII,R-HSA-5637810,reactome,EGF
TP53 Regulates Transcription of Caspase Activators and Caspases,R-HSA-6803207,reactome,TP63
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",R-HSA-399721,reactome,GRIA4
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",R-HSA-399721,reactome,DLG4
Cell Cycle,R-HSA-1640170,reactome,YWHAQ
Cell Cycle,R-HSA-1640170,reactome,CDK4
Cell Cycle,R-HSA-1640170,reactome,TUBA4A
Cell Cycle,R-HSA-1640170,reactome,CDC14A
NRAGE signals death through JNK,R-HSA-193648,reactome,NGFR
Triglyceride catabolism,R-HSA-163560,reactome,LIPE
Separation of Sister Chromatids,R-HSA-2467813,reactome,TUBA4A
Binding and Uptake of Ligands by Scavenger Receptors,R-HSA-2173782,reactome,STAB2
Cellular responses to external stimuli,R-HSA-8953897,reactome,TUBA4A
Cellular responses to external stimuli,R-HSA-8953897,reactome,CDK4
Mitotic Anaphase,R-HSA-68882,reactome,TUBA4A
Neurotransmitter receptors and postsynaptic signal transmission,R-HSA-112314,reactome,GNB5
Neurotransmitter receptors and postsynaptic signal transmission,R-HSA-112314,reactome,GRIA4
Neurotransmitter receptors and postsynaptic signal transmission,R-HSA-112314,reactome,GNG7
Neurotransmitter receptors and postsynaptic signal transmission,R-HSA-112314,reactome,DLG4
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-75035,reactome,YWHAQ
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,CACNA1C
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,SCN3A
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,CACNB2
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,SCN7A
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,CACNB1
Phase 0 - rapid depolarisation,R-HSA-5576892,reactome,CACNA2D1
Negative regulation of MAPK pathway,R-HSA-5675221,reactome,DUSP16
Negative regulation of MAPK pathway,R-HSA-5675221,reactome,DUSP5
HATs acetylate histones,R-HSA-3214847,reactome,USP22
MET activates PTK2 signaling,R-HSA-8874081,reactome,LAMA1
MET activates PTK2 signaling,R-HSA-8874081,reactome,ITGA3
G protein gated Potassium channels,R-HSA-1296059,reactome,GNG7
Inhibition of Signaling by Overexpressed EGFR,R-HSA-5638303,reactome,EGF
ARMS-mediated activation,R-HSA-170984,reactome,IL17RD
ARMS-mediated activation,R-HSA-170984,reactome,EGF
ARMS-mediated activation,R-HSA-170984,reactome,NRG1
ARMS-mediated activation,R-HSA-170984,reactome,DLG4
ARMS-mediated activation,R-HSA-170984,reactome,DUSP5
ARMS-mediated activation,R-HSA-170984,reactome,DUSP16
Organic cation/anion/zwitterion transport,R-HSA-549132,reactome,SLC22A4
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,IL17RD
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,TNFRSF11B
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,IRAK2
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,PIP5K1A
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,LIF
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,DUSP16
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,IER3
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,DUSP5
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,LIFR
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,IL4R
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,NRG1
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,EIF4A3
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,EGF
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,DLG4
Cytokine Signaling in Immune system,R-HSA-1280215,reactome,PIAS1
G alpha (z) signalling events,R-HSA-418597,reactome,GNG7
G alpha (z) signalling events,R-HSA-418597,reactome,ADRA2A
G alpha (z) signalling events,R-HSA-418597,reactome,GNB5
Intrinsic Pathway for Apoptosis,R-HSA-109606,reactome,TP63
Intrinsic Pathway for Apoptosis,R-HSA-109606,reactome,YWHAQ
SHC1 events in ERBB2 signaling,R-HSA-1250196,reactome,NRG1
SHC1 events in ERBB2 signaling,R-HSA-1250196,reactome,EGF
Major pathway of rRNA processing in the nucleolus and cytosol,R-HSA-6791226,reactome,FBL
ADP signalling through P2Y purinoceptor 12,R-HSA-392170,reactome,GNG7
ADP signalling through P2Y purinoceptor 12,R-HSA-392170,reactome,GNB5
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,R-HSA-975163,reactome,IRAK2
RIPK1-mediated regulated necrosis,R-HSA-5213460,reactome,TNFRSF10B
Crosslinking of collagen fibrils,R-HSA-2243919,reactome,COL4A6
Programmed Cell Death,R-HSA-5357801,reactome,TNFRSF10B
Programmed Cell Death,R-HSA-5357801,reactome,TP63
Programmed Cell Death,R-HSA-5357801,reactome,YWHAQ
Ras activation uopn Ca2+ infux through NMDA receptor,R-HSA-442982,reactome,DLG4
RHO GTPases activate PKNs,R-HSA-5625740,reactome,YWHAQ
G alpha (s) signalling events,R-HSA-418555,reactome,GNB5
G alpha (s) signalling events,R-HSA-418555,reactome,VIPR2
G alpha (s) signalling events,R-HSA-418555,reactome,GNG7
Degradation of GABA,R-HSA-916853,reactome,ABAT
S Phase,R-HSA-69242,reactome,CDK4
Processing of Capped Intron-Containing Pre-mRNA,R-HSA-72203,reactome,SF3B3
Processing of Capped Intron-Containing Pre-mRNA,R-HSA-72203,reactome,EIF4A3
Processing of Capped Intron-Containing Pre-mRNA,R-HSA-72203,reactome,NXF1
IRS-mediated signalling,R-HSA-112399,reactome,DUSP16
IRS-mediated signalling,R-HSA-112399,reactome,DLG4
IRS-mediated signalling,R-HSA-112399,reactome,IL17RD
IRS-mediated signalling,R-HSA-112399,reactome,NRG1
IRS-mediated signalling,R-HSA-112399,reactome,DUSP5
IRS-mediated signalling,R-HSA-112399,reactome,EGF
Digestion,R-HSA-8935690,reactome,AMY2A
Digestion,R-HSA-8935690,reactome,AMY1A
Digestion,R-HSA-8935690,reactome,TREH
Transport of Mature mRNA derived from an Intron-Containing Transcript,R-HSA-159236,reactome,NXF1
Transport of Mature mRNA derived from an Intron-Containing Transcript,R-HSA-159236,reactome,EIF4A3
Signaling by EGFR in Cancer,R-HSA-1643713,reactome,EGF
Interconversion of nucleotide di- and triphosphates,R-HSA-499943,reactome,AK5
Digestion of dietary carbohydrate,R-HSA-189085,reactome,AMY1A
Digestion of dietary carbohydrate,R-HSA-189085,reactome,TREH
Digestion of dietary carbohydrate,R-HSA-189085,reactome,AMY2A
PI3K events in ERBB4 signaling,R-HSA-1250342,reactome,NRG1
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",R-HSA-446193,reactome,ALG13
Activation of BAD and translocation to mitochondria ,R-HSA-111447,reactome,YWHAQ
Regulation of necroptotic cell death,R-HSA-5675482,reactome,TNFRSF10B
Diseases of signal transduction,R-HSA-5663202,reactome,LRP6
Diseases of signal transduction,R-HSA-5663202,reactome,NRG1
Diseases of signal transduction,R-HSA-5663202,reactome,EGF
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042,reactome,GNB5
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042,reactome,CACNA1C
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042,reactome,ADRA2A
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042,reactome,GNG7
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042,reactome,CACNB2
Glucose metabolism,R-HSA-70326,reactome,PFKP
PCP/CE pathway,R-HSA-4086400,reactome,ROR2
PCP/CE pathway,R-HSA-4086400,reactome,SMURF2
Interleukin-10 signaling,R-HSA-6783783,reactome,LIF
mRNA 3'-end processing,R-HSA-72187,reactome,EIF4A3
Cleavage of Growing Transcript in the Termination Region ,R-HSA-109688,reactome,EIF4A3
Regulation of TP53 Activity through Association with Co-factors,R-HSA-6804759,reactome,TP63
SOS-mediated signalling,R-HSA-112412,reactome,DLG4
SOS-mediated signalling,R-HSA-112412,reactome,DUSP16
SOS-mediated signalling,R-HSA-112412,reactome,EGF
SOS-mediated signalling,R-HSA-112412,reactome,NRG1
SOS-mediated signalling,R-HSA-112412,reactome,IL17RD
SOS-mediated signalling,R-HSA-112412,reactome,DUSP5
Activation of GABAB receptors,R-HSA-991365,reactome,GNG7
NCAM1 interactions,R-HSA-419037,reactome,CACNA1G
NCAM1 interactions,R-HSA-419037,reactome,CACNA1C
NCAM1 interactions,R-HSA-419037,reactome,CACNB1
NCAM1 interactions,R-HSA-419037,reactome,CACNB2
Interleukin-4 and 13 signaling,R-HSA-6785807,reactome,IL4R
Interleukin-4 and 13 signaling,R-HSA-6785807,reactome,LIF
Smooth Muscle Contraction,R-HSA-445355,reactome,TPM4
Smooth Muscle Contraction,R-HSA-445355,reactome,MYLK
Smooth Muscle Contraction,R-HSA-445355,reactome,ACTA2
HS-GAG degradation,R-HSA-2024096,reactome,HPSE2
Axonal growth stimulation,R-HSA-209563,reactome,NGFR
G1 Phase,R-HSA-69236,reactome,CDK4
Molecules associated with elastic fibres,R-HSA-2129379,reactome,TGFB2
Nitric oxide stimulates guanylate cyclase,R-HSA-392154,reactome,KCNMA1
Nitric oxide stimulates guanylate cyclase,R-HSA-392154,reactome,KCNMB1
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,R-HSA-983695,reactome,TRPC1
Insulin receptor signalling cascade,R-HSA-74751,reactome,IL17RD
Insulin receptor signalling cascade,R-HSA-74751,reactome,DUSP5
Insulin receptor signalling cascade,R-HSA-74751,reactome,NRG1
Insulin receptor signalling cascade,R-HSA-74751,reactome,DUSP16
Insulin receptor signalling cascade,R-HSA-74751,reactome,EGF
Insulin receptor signalling cascade,R-HSA-74751,reactome,DLG4
Ion transport by P-type ATPases,R-HSA-936837,reactome,ATP1A2
Ion transport by P-type ATPases,R-HSA-936837,reactome,ATP10D
Ion transport by P-type ATPases,R-HSA-936837,reactome,ATP9B
Ion transport by P-type ATPases,R-HSA-936837,reactome,ATP8B2
Toll Like Receptor 5 (TLR5) Cascade,R-HSA-168176,reactome,IRAK2
Caspase activation via extrinsic apoptotic signalling pathway,R-HSA-5357769,reactome,TNFRSF10B
Cilium Assembly,R-HSA-5617833,reactome,TUBA4A
HS-GAG biosynthesis,R-HSA-2022928,reactome,HS6ST1
CASP8 activity is inhibited,R-HSA-5218900,reactome,TNFRSF10B
COPI-mediated anterograde transport,R-HSA-6807878,reactome,TUBA4A
SUMOylation,R-HSA-2990846,reactome,PIAS1
Regulated Necrosis,R-HSA-5218859,reactome,TNFRSF10B
p75 NTR receptor-mediated signalling,R-HSA-193704,reactome,NGFR
Amino acid synthesis and interconversion (transamination),R-HSA-70614,reactome,ASNS
Regulation of IFNG signaling,R-HSA-877312,reactome,PIAS1
GABA B receptor activation,R-HSA-977444,reactome,GNG7
TRP channels,R-HSA-3295583,reactome,TRPC1
TRP channels,R-HSA-3295583,reactome,TRPM3
Glycolysis,R-HSA-70171,reactome,PFKP
Stimuli-sensing channels,R-HSA-2672351,reactome,TRPM3
Stimuli-sensing channels,R-HSA-2672351,reactome,TRPC1
Stimuli-sensing channels,R-HSA-2672351,reactome,CASQ2
Reversible hydration of carbon dioxide,R-HSA-1475029,reactome,CA12
Hedgehog 'on' state,R-HSA-5632684,reactome,SMURF2
Hedgehog 'on' state,R-HSA-5632684,reactome,GLI3
Hedgehog 'on' state,R-HSA-5632684,reactome,GLI2
IGF1R signaling cascade,R-HSA-2428924,reactome,DUSP5
IGF1R signaling cascade,R-HSA-2428924,reactome,DLG4
IGF1R signaling cascade,R-HSA-2428924,reactome,EGF
IGF1R signaling cascade,R-HSA-2428924,reactome,DUSP16
IGF1R signaling cascade,R-HSA-2428924,reactome,IGF1R
IGF1R signaling cascade,R-HSA-2428924,reactome,IL17RD
IGF1R signaling cascade,R-HSA-2428924,reactome,NRG1
Centrosome maturation,R-HSA-380287,reactome,TUBA4A
Transport of connexons to the plasma membrane,R-HSA-190872,reactome,TUBA4A
Bile acid and bile salt metabolism,R-HSA-194068,reactome,ABCC3
Metabolism of RNA,R-HSA-8953854,reactome,SF3B3
Metabolism of RNA,R-HSA-8953854,reactome,TRMT11
Metabolism of RNA,R-HSA-8953854,reactome,EIF4A3
Metabolism of RNA,R-HSA-8953854,reactome,TRIT1
Metabolism of RNA,R-HSA-8953854,reactome,NXF1
Metabolism of RNA,R-HSA-8953854,reactome,FBL
RNA Polymerase I Transcription Initiation,R-HSA-73762,reactome,POLR1B
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,R-HSA-190840,reactome,TUBA4A
Epigenetic regulation of gene expression,R-HSA-212165,reactome,POLR1B
RHO GTPases Activate Formins,R-HSA-5663220,reactome,TUBA4A
Type I hemidesmosome assembly,R-HSA-446107,reactome,KRT14
EGFR interacts with phospholipase C-gamma,R-HSA-212718,reactome,EGF
Adrenaline signalling through Alpha-2 adrenergic receptor,R-HSA-392023,reactome,ADRA2A
G alpha (i) signalling events,R-HSA-418594,reactome,GNB5
G alpha (i) signalling events,R-HSA-418594,reactome,ADRA2A
G alpha (i) signalling events,R-HSA-418594,reactome,GNG7
G alpha (i) signalling events,R-HSA-418594,reactome,PTGER3
Signaling by ERBB2,R-HSA-1227986,reactome,NRG1
Signaling by ERBB2,R-HSA-1227986,reactome,EGF
Presynaptic depolarization and calcium channel opening,R-HSA-112308,reactome,CACNB1
Presynaptic depolarization and calcium channel opening,R-HSA-112308,reactome,CACNB2
SUMOylation of chromatin organization proteins,R-HSA-4551638,reactome,PIAS1
Regulation of RUNX3 expression and activity,R-HSA-8941858,reactome,SMURF2
Phospholipid metabolism,R-HSA-1483257,reactome,PNPLA2
Phospholipid metabolism,R-HSA-1483257,reactome,PIK3C2G
Phospholipid metabolism,R-HSA-1483257,reactome,SLC44A1
Phospholipid metabolism,R-HSA-1483257,reactome,PIP5K1A
Phospholipid metabolism,R-HSA-1483257,reactome,PNPLA7
RUNX1 regulates transcription of genes involved in interleukin signaling,R-HSA-8939247,reactome,LIFR
Chromatin organization,R-HSA-4839726,reactome,USP22
Chromatin organization,R-HSA-4839726,reactome,CDK4
DAP12 signaling,R-HSA-2424491,reactome,DUSP16
DAP12 signaling,R-HSA-2424491,reactome,NRG1
DAP12 signaling,R-HSA-2424491,reactome,EGF
DAP12 signaling,R-HSA-2424491,reactome,PIP5K1A
DAP12 signaling,R-HSA-2424491,reactome,IER3
DAP12 signaling,R-HSA-2424491,reactome,IL17RD
DAP12 signaling,R-HSA-2424491,reactome,DUSP5
DAP12 signaling,R-HSA-2424491,reactome,DLG4
Post-translational modification: synthesis of GPI-anchored proteins,R-HSA-163125,reactome,PIGL
Abacavir metabolism,R-HSA-2161541,reactome,NT5C2
Signalling by NGF,R-HSA-166520,reactome,IER3
Signalling by NGF,R-HSA-166520,reactome,DLG4
Signalling by NGF,R-HSA-166520,reactome,DUSP5
Signalling by NGF,R-HSA-166520,reactome,NRG1
Signalling by NGF,R-HSA-166520,reactome,EGF
Signalling by NGF,R-HSA-166520,reactome,PIP5K1A
Signalling by NGF,R-HSA-166520,reactome,NGFR
Signalling by NGF,R-HSA-166520,reactome,IL17RD
Signalling by NGF,R-HSA-166520,reactome,DUSP16
"Transport of bile salts and organic acids, metal ions and amine compounds",R-HSA-425366,reactome,SLC14A2
"Transport of bile salts and organic acids, metal ions and amine compounds",R-HSA-425366,reactome,SLC44A1
"Transport of bile salts and organic acids, metal ions and amine compounds",R-HSA-425366,reactome,SLC22A4
Mitochondrial tRNA aminoacylation,R-HSA-379726,reactome,AARS2
Phase II - Conjugation of compounds,R-HSA-156580,reactome,GSTM5
Role of second messengers in netrin-1 signaling,R-HSA-418890,reactome,TRPC1
Cardiac conduction,R-HSA-5576891,reactome,KCNIP1
Cardiac conduction,R-HSA-5576891,reactome,KCNIP2
Cardiac conduction,R-HSA-5576891,reactome,CACNA1C
Cardiac conduction,R-HSA-5576891,reactome,CACNA2D1
Cardiac conduction,R-HSA-5576891,reactome,CASQ2
Cardiac conduction,R-HSA-5576891,reactome,TRPC1
Cardiac conduction,R-HSA-5576891,reactome,CACNB2
Cardiac conduction,R-HSA-5576891,reactome,CACNB1
Cardiac conduction,R-HSA-5576891,reactome,SCN7A
Cardiac conduction,R-HSA-5576891,reactome,SCN3A
Cardiac conduction,R-HSA-5576891,reactome,ATP1A2
Signaling by BMP,R-HSA-201451,reactome,SMURF2
RNA Polymerase I Chain Elongation,R-HSA-73777,reactome,POLR1B
RHO GTPases activate CIT,R-HSA-5625900,reactome,DLG4
Dimerization of procaspase-8,R-HSA-69416,reactome,TNFRSF10B
Synthesis of glycosylphosphatidylinositol (GPI),R-HSA-162710,reactome,PIGL
Post-translational protein modification,R-HSA-597592,reactome,UBE2Z
Post-translational protein modification,R-HSA-597592,reactome,STC2
Post-translational protein modification,R-HSA-597592,reactome,GALNT10
Post-translational protein modification,R-HSA-597592,reactome,PIGL
Post-translational protein modification,R-HSA-597592,reactome,C4A
Post-translational protein modification,R-HSA-597592,reactome,PIAS1
Post-translational protein modification,R-HSA-597592,reactome,TUBA4A
Post-translational protein modification,R-HSA-597592,reactome,IGFBP4
Post-translational protein modification,R-HSA-597592,reactome,ALG13
Post-translational protein modification,R-HSA-597592,reactome,PNPLA2
Post-translational protein modification,R-HSA-597592,reactome,SMURF2
Post-translational protein modification,R-HSA-597592,reactome,USP11
Post-translational protein modification,R-HSA-597592,reactome,TNC
Post-translational protein modification,R-HSA-597592,reactome,USP22
Toxicity of botulinum toxin type E (BoNT/E),R-HSA-5250992,reactome,SV2A
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,ADRA2A
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,OXTR
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,PROK1
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,F2R
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,GRPR
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,PTGER3
Class A/1 (Rhodopsin-like receptors),R-HSA-373076,reactome,LPPR2
G-protein mediated events,R-HSA-112040,reactome,PLCB4
Beta oxidation of butanoyl-CoA to acetyl-CoA,R-HSA-77352,reactome,ACADS
Beta oxidation of butanoyl-CoA to acetyl-CoA,R-HSA-77352,reactome,ACSM3
Fatty acid metabolism,R-HSA-8978868,reactome,PPT2
Fatty acid metabolism,R-HSA-8978868,reactome,ACOT2
Fatty acid metabolism,R-HSA-8978868,reactome,ACADS
Fatty acid metabolism,R-HSA-8978868,reactome,SCD5
Fatty acid metabolism,R-HSA-8978868,reactome,ACSM3
Transcriptional regulation by RUNX1,R-HSA-8878171,reactome,LIFR
Transcriptional regulation by RUNX1,R-HSA-8878171,reactome,NR4A3
Sulfur amino acid metabolism,R-HSA-1614635,reactome,BHMT2
CREB phosphorylation through the activation of CaMKII,R-HSA-442729,reactome,DLG4
Protein folding,R-HSA-391251,reactome,GNG7
Protein folding,R-HSA-391251,reactome,USP11
Protein folding,R-HSA-391251,reactome,GNB5
Protein folding,R-HSA-391251,reactome,TUBA4A
Cyclin D associated events in G1,R-HSA-69231,reactome,CDK4
rRNA modification in the nucleus and cytosol,R-HSA-6790901,reactome,FBL
Toll Like Receptor TLR6:TLR2 Cascade,R-HSA-168188,reactome,IRAK2
VEGFR2 mediated vascular permeability,R-HSA-5218920,reactome,PAK3
Downregulation of ERBB2 signaling,R-HSA-8863795,reactome,NRG1
Downregulation of ERBB2 signaling,R-HSA-8863795,reactome,EGF
Common Pathway of Fibrin Clot Formation,R-HSA-140875,reactome,F2R
Common Pathway of Fibrin Clot Formation,R-HSA-140875,reactome,THBD
Interleukin receptor SHC signaling,R-HSA-912526,reactome,NRG1
Interleukin receptor SHC signaling,R-HSA-912526,reactome,DUSP16
Interleukin receptor SHC signaling,R-HSA-912526,reactome,DLG4
Interleukin receptor SHC signaling,R-HSA-912526,reactome,IL17RD
Interleukin receptor SHC signaling,R-HSA-912526,reactome,DUSP5
Interleukin receptor SHC signaling,R-HSA-912526,reactome,EGF
Prostacyclin signalling through prostacyclin receptor,R-HSA-392851,reactome,GNB5
Prostacyclin signalling through prostacyclin receptor,R-HSA-392851,reactome,GNG7
Factors involved in megakaryocyte development and platelet production,R-HSA-983231,reactome,TUBA4A
Factors involved in megakaryocyte development and platelet production,R-HSA-983231,reactome,DOCK5
Factors involved in megakaryocyte development and platelet production,R-HSA-983231,reactome,EHD2
Factors involved in megakaryocyte development and platelet production,R-HSA-983231,reactome,MAFF
Ion homeostasis,R-HSA-5578775,reactome,CASQ2
Ion homeostasis,R-HSA-5578775,reactome,ATP1A2
Ion homeostasis,R-HSA-5578775,reactome,TRPC1
Innate Immune System,R-HSA-168249,reactome,DLG4
Innate Immune System,R-HSA-168249,reactome,PGM2
Innate Immune System,R-HSA-168249,reactome,IRAK2
Innate Immune System,R-HSA-168249,reactome,DUSP5
Innate Immune System,R-HSA-168249,reactome,PPAPDC1B
Innate Immune System,R-HSA-168249,reactome,ANPEP
Innate Immune System,R-HSA-168249,reactome,IER3
Innate Immune System,R-HSA-168249,reactome,CFI
Innate Immune System,R-HSA-168249,reactome,DSC1
Innate Immune System,R-HSA-168249,reactome,PIP5K1A
Innate Immune System,R-HSA-168249,reactome,IL17RD
Innate Immune System,R-HSA-168249,reactome,EGF
Innate Immune System,R-HSA-168249,reactome,DUSP16
Innate Immune System,R-HSA-168249,reactome,NRG1
Innate Immune System,R-HSA-168249,reactome,C4A
Innate Immune System,R-HSA-168249,reactome,PAK3
Downregulation of ERBB2:ERBB3 signaling,R-HSA-1358803,reactome,NRG1
L1CAM interactions,R-HSA-373760,reactome,DLG4
L1CAM interactions,R-HSA-373760,reactome,LAMA1
L1CAM interactions,R-HSA-373760,reactome,TUBA4A
L1CAM interactions,R-HSA-373760,reactome,SCN7A
L1CAM interactions,R-HSA-373760,reactome,SCN3A
Transport of Mature Transcript to Cytoplasm,R-HSA-72202,reactome,EIF4A3
Transport of Mature Transcript to Cytoplasm,R-HSA-72202,reactome,NXF1
The retinoid cycle in cones (daylight vision),R-HSA-2187335,reactome,DHRS3
Regulation of insulin secretion,R-HSA-422356,reactome,ADRA2A
Regulation of insulin secretion,R-HSA-422356,reactome,GNB5
Regulation of insulin secretion,R-HSA-422356,reactome,CACNA1C
Regulation of insulin secretion,R-HSA-422356,reactome,CACNB2
Regulation of insulin secretion,R-HSA-422356,reactome,GNG7
RNA Polymerase I Transcription,R-HSA-73864,reactome,POLR1B
Complement cascade,R-HSA-166658,reactome,C4A
Complement cascade,R-HSA-166658,reactome,CFI
Ceramide signalling,R-HSA-193681,reactome,NGFR
Oncogene Induced Senescence,R-HSA-2559585,reactome,CDK4
Toll Like Receptor 3 (TLR3) Cascade,R-HSA-168164,reactome,IRAK2
GRB2 events in EGFR signaling,R-HSA-179812,reactome,EGF
GRB2 events in EGFR signaling,R-HSA-179812,reactome,DLG4
GRB2 events in EGFR signaling,R-HSA-179812,reactome,IL17RD
GRB2 events in EGFR signaling,R-HSA-179812,reactome,NRG1
GRB2 events in EGFR signaling,R-HSA-179812,reactome,DUSP16
GRB2 events in EGFR signaling,R-HSA-179812,reactome,DUSP5
Immune System,R-HSA-168256,reactome,UBE2Z
Immune System,R-HSA-168256,reactome,LIFR
Immune System,R-HSA-168256,reactome,IRAK2
Immune System,R-HSA-168256,reactome,TNFRSF11B
Immune System,R-HSA-168256,reactome,PGM2
Immune System,R-HSA-168256,reactome,TUBA4A
Immune System,R-HSA-168256,reactome,TRPC1
Immune System,R-HSA-168256,reactome,EIF4A3
Immune System,R-HSA-168256,reactome,CFI
Immune System,R-HSA-168256,reactome,IL4R
Immune System,R-HSA-168256,reactome,DUSP5
Immune System,R-HSA-168256,reactome,PIAS1
Immune System,R-HSA-168256,reactome,C4A
Immune System,R-HSA-168256,reactome,DUSP16
Immune System,R-HSA-168256,reactome,ANPEP
Immune System,R-HSA-168256,reactome,PAK3
Immune System,R-HSA-168256,reactome,IER3
Immune System,R-HSA-168256,reactome,SMURF2
Immune System,R-HSA-168256,reactome,NRG1
Immune System,R-HSA-168256,reactome,PPAPDC1B
Immune System,R-HSA-168256,reactome,LIF
Immune System,R-HSA-168256,reactome,EGF
Immune System,R-HSA-168256,reactome,PIP5K1A
Immune System,R-HSA-168256,reactome,IL17RD
Immune System,R-HSA-168256,reactome,DSC1
Immune System,R-HSA-168256,reactome,DLG4
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321,reactome,IRAK2
NoRC negatively regulates rRNA expression,R-HSA-427413,reactome,POLR1B
Regulation of Complement cascade,R-HSA-977606,reactome,CFI
Regulation of Complement cascade,R-HSA-977606,reactome,C4A
Synthesis of PIPs at the plasma membrane,R-HSA-1660499,reactome,PIP5K1A
Synthesis of PIPs at the plasma membrane,R-HSA-1660499,reactome,PIK3C2G
Axonal growth inhibition (RHOA activation),R-HSA-193634,reactome,NGFR
Deadenylation of mRNA,R-HSA-429947,reactome,EIF4A3
CREB phosphorylation through the activation of Ras,R-HSA-442742,reactome,DLG4
MyD88 cascade initiated on plasma membrane,R-HSA-975871,reactome,IRAK2
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,R-HSA-1236382,reactome,EGF
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,R-HSA-6803204,reactome,TP63
mRNA Splicing - Minor Pathway,R-HSA-72165,reactome,SF3B3
Post-translational protein phosphorylation,R-HSA-8957275,reactome,C4A
Post-translational protein phosphorylation,R-HSA-8957275,reactome,TNC
Post-translational protein phosphorylation,R-HSA-8957275,reactome,STC2
Post-translational protein phosphorylation,R-HSA-8957275,reactome,PNPLA2
Post-translational protein phosphorylation,R-HSA-8957275,reactome,IGFBP4
RNA Polymerase I Transcription Termination,R-HSA-73863,reactome,POLR1B
Gene expression (Transcription),R-HSA-74160,reactome,EIF4A3
Gene expression (Transcription),R-HSA-74160,reactome,SMURF2
Gene expression (Transcription),R-HSA-74160,reactome,POLR1B
Gene expression (Transcription),R-HSA-74160,reactome,TP63
Gene expression (Transcription),R-HSA-74160,reactome,LIFR
Gene expression (Transcription),R-HSA-74160,reactome,NR4A3
Gene expression (Transcription),R-HSA-74160,reactome,TNFRSF10B
Gene expression (Transcription),R-HSA-74160,reactome,YWHAQ
Signaling by VEGF,R-HSA-194138,reactome,NRG1
Signaling by VEGF,R-HSA-194138,reactome,PAK3
Signaling by VEGF,R-HSA-194138,reactome,DUSP16
Signaling by VEGF,R-HSA-194138,reactome,IL17RD
Signaling by VEGF,R-HSA-194138,reactome,EGF
Signaling by VEGF,R-HSA-194138,reactome,AXL
Signaling by VEGF,R-HSA-194138,reactome,DLG4
Signaling by VEGF,R-HSA-194138,reactome,DUSP5
Cellular Senescence,R-HSA-2559583,reactome,CDK4
Synthesis of PC,R-HSA-1483191,reactome,SLC44A1
Signaling by ERBB4,R-HSA-1236394,reactome,NRG1
Signaling by ERBB4,R-HSA-1236394,reactome,EGF
O-linked glycosylation of mucins,R-HSA-913709,reactome,GALNT10
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,NRG1
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,DUSP5
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,PIP5K1A
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,IL17RD
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,DUSP16
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,EGF
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,IER3
NGF signalling via TRKA from the plasma membrane,R-HSA-187037,reactome,DLG4
Thromboxane signalling through TP receptor,R-HSA-428930,reactome,GNB5
Thromboxane signalling through TP receptor,R-HSA-428930,reactome,GNG7
NOD1/2 Signaling Pathway,R-HSA-168638,reactome,IRAK2
Ionotropic activity of kainate receptors,R-HSA-451306,reactome,DLG4
Glycogen synthesis,R-HSA-3322077,reactome,PGM2
Mitochondrial Fatty Acid Beta-Oxidation,R-HSA-77289,reactome,ACSM3
Mitochondrial Fatty Acid Beta-Oxidation,R-HSA-77289,reactome,ACADS
Mitochondrial Fatty Acid Beta-Oxidation,R-HSA-77289,reactome,ACOT2
SUMO E3 ligases SUMOylate target proteins,R-HSA-3108232,reactome,PIAS1
Neutrophil degranulation,R-HSA-6798695,reactome,PGM2
Neutrophil degranulation,R-HSA-6798695,reactome,ANPEP
Neutrophil degranulation,R-HSA-6798695,reactome,DSC1
MAPK6/MAPK4 signaling,R-HSA-5687128,reactome,PAK3
MAPK6/MAPK4 signaling,R-HSA-5687128,reactome,CDC14A
"Cell death signalling via NRAGE, NRIF and NADE",R-HSA-204998,reactome,NGFR
Cell surface interactions at the vascular wall,R-HSA-202733,reactome,THBD
Cell surface interactions at the vascular wall,R-HSA-202733,reactome,TNFRSF10B
Cell surface interactions at the vascular wall,R-HSA-202733,reactome,ITGA3
Transcriptional regulation of white adipocyte differentiation,R-HSA-381340,reactome,CDK4
RNA Polymerase I Promoter Clearance,R-HSA-73854,reactome,POLR1B
Regulation of TP53 Activity,R-HSA-5633007,reactome,TP63
NFG and proNGF binds to p75NTR,R-HSA-205017,reactome,NGFR
Signal amplification,R-HSA-392518,reactome,GNB5
Signal amplification,R-HSA-392518,reactome,GNG7
Regulation of PLK1 Activity at G2/M Transition,R-HSA-2565942,reactome,TUBA4A
Transport of the SLBP Dependant Mature mRNA,R-HSA-159230,reactome,NXF1
Glycogen metabolism,R-HSA-8982491,reactome,PHKG2
Glycogen metabolism,R-HSA-8982491,reactome,PGM2
Visual phototransduction,R-HSA-2187338,reactome,DHRS3
Visual phototransduction,R-HSA-2187338,reactome,RCVRN
RNA Polymerase II Transcription Termination,R-HSA-73856,reactome,EIF4A3
GABA receptor activation,R-HSA-977443,reactome,GNG7
APC/C-mediated degradation of cell cycle proteins,R-HSA-174143,reactome,CDC14A
Nuclear signaling by ERBB4,R-HSA-1251985,reactome,NRG1
Activation of AMPA receptors,R-HSA-399710,reactome,GRIA4
Vesicle-mediated transport,R-HSA-5653656,reactome,TUBA4A
Vesicle-mediated transport,R-HSA-5653656,reactome,YWHAQ
Vesicle-mediated transport,R-HSA-5653656,reactome,EGF
Vesicle-mediated transport,R-HSA-5653656,reactome,STAB2
Class I MHC mediated antigen processing & presentation,R-HSA-983169,reactome,SMURF2
Class I MHC mediated antigen processing & presentation,R-HSA-983169,reactome,UBE2Z
ER to Golgi Anterograde Transport,R-HSA-199977,reactome,TUBA4A
Glutathione conjugation,R-HSA-156590,reactome,GSTM5
Meiotic recombination,R-HSA-912446,reactome,CDK4
Translation,R-HSA-72766,reactome,LARS
Translation,R-HSA-72766,reactome,AARS2
Purine catabolism,R-HSA-74259,reactome,NT5C2
"Cell Cycle, Mitotic",R-HSA-69278,reactome,CDK4
"Cell Cycle, Mitotic",R-HSA-69278,reactome,CDC14A
"Cell Cycle, Mitotic",R-HSA-69278,reactome,TUBA4A
Toll Like Receptor 4 (TLR4) Cascade,R-HSA-166016,reactome,IRAK2
Regulation of mitotic cell cycle,R-HSA-453276,reactome,CDC14A
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,DLG4
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,DUSP16
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,EGF
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,NRG1
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,DUSP5
"Interleukin-19,20,22,24,26,28 and 29 signaling",R-HSA-8854691,reactome,IL17RD
PI3K/AKT activation,R-HSA-198203,reactome,EGF
PI3K/AKT activation,R-HSA-198203,reactome,IER3
PI3K/AKT activation,R-HSA-198203,reactome,PIP5K1A
PI3K/AKT activation,R-HSA-198203,reactome,NRG1
PI3K/AKT Signaling in Cancer,R-HSA-2219528,reactome,EGF
PI3K/AKT Signaling in Cancer,R-HSA-2219528,reactome,NRG1
"GABA synthesis, release, reuptake and degradation",R-HSA-888590,reactome,ABAT
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,IER3
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,DLG4
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,PIP5K1A
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,DUSP5
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,DUSP16
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,NRG1
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,IL17RD
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202,reactome,EGF
Apoptosis,R-HSA-109581,reactome,TNFRSF10B
Apoptosis,R-HSA-109581,reactome,YWHAQ
Apoptosis,R-HSA-109581,reactome,TP63
Laminin interactions,R-HSA-3000157,reactome,COL4A6
Laminin interactions,R-HSA-3000157,reactome,LAMA1
Laminin interactions,R-HSA-3000157,reactome,ITGA3
Translocation of GLUT4 to the plasma membrane,R-HSA-1445148,reactome,YWHAQ
Translocation of GLUT4 to the plasma membrane,R-HSA-1445148,reactome,TUBA4A
Transcriptional regulation by RUNX3,R-HSA-8878159,reactome,SMURF2
Digestion and absorption,R-HSA-8963743,reactome,TREH
Digestion and absorption,R-HSA-8963743,reactome,AMY1A
Digestion and absorption,R-HSA-8963743,reactome,AMY2A
Cell-Cell communication,R-HSA-1500931,reactome,KRT14
Cell-Cell communication,R-HSA-1500931,reactome,CLDN11
Cell-Cell communication,R-HSA-1500931,reactome,ACTN1
tRNA modification in the nucleus and cytosol,R-HSA-6782315,reactome,TRIT1
tRNA modification in the nucleus and cytosol,R-HSA-6782315,reactome,TRMT11
Loss of Nlp from mitotic centrosomes,R-HSA-380259,reactome,TUBA4A
RHO GTPase Effectors,R-HSA-195258,reactome,MYLK
RHO GTPase Effectors,R-HSA-195258,reactome,PAK3
RHO GTPase Effectors,R-HSA-195258,reactome,DLG4
RHO GTPase Effectors,R-HSA-195258,reactome,TUBA4A
RHO GTPase Effectors,R-HSA-195258,reactome,YWHAQ
Positive epigenetic regulation of rRNA expression,R-HSA-5250913,reactome,POLR1B
Signaling by Insulin receptor,R-HSA-74752,reactome,DUSP5
Signaling by Insulin receptor,R-HSA-74752,reactome,IL17RD
Signaling by Insulin receptor,R-HSA-74752,reactome,DLG4
Signaling by Insulin receptor,R-HSA-74752,reactome,EGF
Signaling by Insulin receptor,R-HSA-74752,reactome,DUSP16
Signaling by Insulin receptor,R-HSA-74752,reactome,NRG1
Toll Like Receptor 2 (TLR2) Cascade,R-HSA-181438,reactome,IRAK2
DAP12 interactions,R-HSA-2172127,reactome,DUSP16
DAP12 interactions,R-HSA-2172127,reactome,PIP5K1A
DAP12 interactions,R-HSA-2172127,reactome,IL17RD
DAP12 interactions,R-HSA-2172127,reactome,DUSP5
DAP12 interactions,R-HSA-2172127,reactome,DLG4
DAP12 interactions,R-HSA-2172127,reactome,EGF
DAP12 interactions,R-HSA-2172127,reactome,NRG1
DAP12 interactions,R-HSA-2172127,reactome,IER3
Transport of Mature mRNAs Derived from Intronless Transcripts,R-HSA-159234,reactome,NXF1
IRAK2 mediated activation of TAK1 complex,R-HSA-937042,reactome,IRAK2
Activation of Matrix Metalloproteinases,R-HSA-1592389,reactome,MMP16
RORA activates gene expression,R-HSA-1368082,reactome,NPAS2
TP53 Regulates Metabolic Genes,R-HSA-5628897,reactome,YWHAQ
TP53 Regulates Metabolic Genes,R-HSA-5628897,reactome,TP63
Negative regulation of the PI3K/AKT network,R-HSA-199418,reactome,PIP5K1A
Negative regulation of the PI3K/AKT network,R-HSA-199418,reactome,NRG1
Negative regulation of the PI3K/AKT network,R-HSA-199418,reactome,EGF
Negative regulation of the PI3K/AKT network,R-HSA-199418,reactome,IER3
GRB7 events in ERBB2 signaling,R-HSA-1306955,reactome,NRG1
Fatty acyl-CoA biosynthesis,R-HSA-75105,reactome,SCD5
Fatty acyl-CoA biosynthesis,R-HSA-75105,reactome,PPT2
Interleukin-6 family signaling,R-HSA-6783589,reactome,LIF
Interleukin-6 family signaling,R-HSA-6783589,reactome,LIFR
Galactose catabolism,R-HSA-70370,reactome,PGM2
PPARA activates gene expression,R-HSA-1989781,reactome,NPAS2
PPARA activates gene expression,R-HSA-1989781,reactome,FHL2
Circadian Clock,R-HSA-400253,reactome,CRY1
Circadian Clock,R-HSA-400253,reactome,NPAS2
Circadian Clock,R-HSA-400253,reactome,CRY2
Circadian Clock,R-HSA-400253,reactome,BHLHE40
Circadian Clock,R-HSA-400253,reactome,PER2
SHC-related events triggered by IGF1R,R-HSA-2428933,reactome,IGF1R
Formation of Incision Complex in GG-NER,R-HSA-5696395,reactome,PIAS1
Gap junction trafficking,R-HSA-190828,reactome,TUBA4A
Vasopressin regulates renal water homeostasis via Aquaporins,R-HSA-432040,reactome,GNB5
Vasopressin regulates renal water homeostasis via Aquaporins,R-HSA-432040,reactome,GNG7
Sphingolipid metabolism,R-HSA-428157,reactome,SGPP1
Downstream signaling events of B Cell Receptor (BCR),R-HSA-1168372,reactome,IER3
Downstream signaling events of B Cell Receptor (BCR),R-HSA-1168372,reactome,EGF
Downstream signaling events of B Cell Receptor (BCR),R-HSA-1168372,reactome,PIP5K1A
Downstream signaling events of B Cell Receptor (BCR),R-HSA-1168372,reactome,NRG1
Glutamate Neurotransmitter Release Cycle,R-HSA-210500,reactome,SLC17A7
Recruitment of NuMA to mitotic centrosomes,R-HSA-380320,reactome,TUBA4A
Mitotic Metaphase and Anaphase,R-HSA-2555396,reactome,TUBA4A
Integrin cell surface interactions,R-HSA-216083,reactome,COL4A6
Integrin cell surface interactions,R-HSA-216083,reactome,ITGA3
Integrin cell surface interactions,R-HSA-216083,reactome,TNC
AURKA Activation by TPX2,R-HSA-8854518,reactome,TUBA4A
Semaphorin interactions,R-HSA-373755,reactome,PAK3
Degradation of GLI2 by the proteasome,R-HSA-5610783,reactome,GLI2
Activation of kainate receptors upon glutamate binding,R-HSA-451326,reactome,GNG7
Activation of kainate receptors upon glutamate binding,R-HSA-451326,reactome,GNB5
Activation of kainate receptors upon glutamate binding,R-HSA-451326,reactome,DLG4
Keratinization,R-HSA-6805567,reactome,DSC1
Keratinization,R-HSA-6805567,reactome,KRT14
Toll-Like Receptors Cascades,R-HSA-168898,reactome,IRAK2
EGFR downregulation,R-HSA-182971,reactome,EGF
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,R-HSA-997272,reactome,GNG7
Activation of BH3-only proteins,R-HSA-114452,reactome,YWHAQ
Activation of BH3-only proteins,R-HSA-114452,reactome,TP63
NADE modulates death signalling,R-HSA-205025,reactome,NGFR
C-type lectin receptors (CLRs),R-HSA-5621481,reactome,PAK3
Tight junction interactions,R-HSA-420029,reactome,CLDN11
Protein-protein interactions at synapses,R-HSA-6794362,reactome,GRIA4
Protein-protein interactions at synapses,R-HSA-6794362,reactome,DLG4
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,R-HSA-176407,reactome,CDC14A
IL-6-type cytokine receptor ligand interactions,R-HSA-6788467,reactome,LIFR
IL-6-type cytokine receptor ligand interactions,R-HSA-6788467,reactome,LIF
MHC class II antigen presentation,R-HSA-2132295,reactome,TUBA4A
TP53 Regulates Transcription of Cell Death Genes,R-HSA-5633008,reactome,TP63
TP53 Regulates Transcription of Cell Death Genes,R-HSA-5633008,reactome,TNFRSF10B
G2/M DNA damage checkpoint,R-HSA-69473,reactome,YWHAQ
PI Metabolism,R-HSA-1483255,reactome,PIK3C2G
PI Metabolism,R-HSA-1483255,reactome,PIP5K1A
PI Metabolism,R-HSA-1483255,reactome,PNPLA7
cGMP effects,R-HSA-418457,reactome,KCNMB1
cGMP effects,R-HSA-418457,reactome,KCNMA1
Signaling by EGFR,R-HSA-177929,reactome,EGF
Signaling by EGFR,R-HSA-177929,reactome,IER3
Signaling by EGFR,R-HSA-177929,reactome,DLG4
Signaling by EGFR,R-HSA-177929,reactome,DUSP16
Signaling by EGFR,R-HSA-177929,reactome,PIP5K1A
Signaling by EGFR,R-HSA-177929,reactome,NRG1
Signaling by EGFR,R-HSA-177929,reactome,IL17RD
Signaling by EGFR,R-HSA-177929,reactome,DUSP5
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,R-HSA-77350,reactome,ACADS
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989,reactome,IRAK2
GPCR ligand binding,R-HSA-500792,reactome,GNB5
GPCR ligand binding,R-HSA-500792,reactome,PROK1
GPCR ligand binding,R-HSA-500792,reactome,GRPR
GPCR ligand binding,R-HSA-500792,reactome,VIPR2
GPCR ligand binding,R-HSA-500792,reactome,PTGER3
GPCR ligand binding,R-HSA-500792,reactome,OXTR
GPCR ligand binding,R-HSA-500792,reactome,ADRA2A
GPCR ligand binding,R-HSA-500792,reactome,LPPR2
GPCR ligand binding,R-HSA-500792,reactome,GNG7
GPCR ligand binding,R-HSA-500792,reactome,F2R
Transport to the Golgi and subsequent modification,R-HSA-948021,reactome,TUBA4A
Signaling by the B Cell Receptor (BCR),R-HSA-983705,reactome,TRPC1
Signaling by the B Cell Receptor (BCR),R-HSA-983705,reactome,NRG1
Signaling by the B Cell Receptor (BCR),R-HSA-983705,reactome,EGF
Signaling by the B Cell Receptor (BCR),R-HSA-983705,reactome,IER3
Signaling by the B Cell Receptor (BCR),R-HSA-983705,reactome,PIP5K1A
RA biosynthesis pathway,R-HSA-5365859,reactome,DHRS3
RA biosynthesis pathway,R-HSA-5365859,reactome,ALDH1A2
Post NMDA receptor activation events,R-HSA-438064,reactome,DLG4
Signaling by SCF-KIT,R-HSA-1433557,reactome,PIP5K1A
Signaling by SCF-KIT,R-HSA-1433557,reactome,EGF
Signaling by SCF-KIT,R-HSA-1433557,reactome,IL17RD
Signaling by SCF-KIT,R-HSA-1433557,reactome,DUSP5
Signaling by SCF-KIT,R-HSA-1433557,reactome,NRG1
Signaling by SCF-KIT,R-HSA-1433557,reactome,DLG4
Signaling by SCF-KIT,R-HSA-1433557,reactome,DUSP16
Signaling by SCF-KIT,R-HSA-1433557,reactome,IER3
rRNA processing in the nucleus and cytosol,R-HSA-8868773,reactome,FBL
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,DLG4
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,NRG1
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,DUSP5
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,DUSP16
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,EGF
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,IL17RD
Acyl chain remodeling of DAG and TAG,R-HSA-1482883,reactome,PNPLA2
GLI proteins bind promoters of Hh responsive genes to promote transcription,R-HSA-5635851,reactome,GLI2
GLI proteins bind promoters of Hh responsive genes to promote transcription,R-HSA-5635851,reactome,GLI3
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,ADRA2A
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,TGFB2
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,EGF
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,GNB5
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,GNG7
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,ACTN1
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,TUBA4A
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,DGKA
"Platelet activation, signaling and aggregation",R-HSA-76002,reactome,F2R
TRAIL  signaling,R-HSA-75158,reactome,TNFRSF10B
Toll Like Receptor TLR1:TLR2 Cascade,R-HSA-168179,reactome,IRAK2
G1/S Transition,R-HSA-69206,reactome,CDK4
Toll Like Receptor 7/8 (TLR7/8) Cascade,R-HSA-168181,reactome,IRAK2
Developmental Biology,R-HSA-1266738,reactome,NRG1
Developmental Biology,R-HSA-1266738,reactome,CACNB1
Developmental Biology,R-HSA-1266738,reactome,KRT14
Developmental Biology,R-HSA-1266738,reactome,CACNA1G
Developmental Biology,R-HSA-1266738,reactome,DSC1
Developmental Biology,R-HSA-1266738,reactome,CACNB2
Developmental Biology,R-HSA-1266738,reactome,DUSP5
Developmental Biology,R-HSA-1266738,reactome,CDK4
Developmental Biology,R-HSA-1266738,reactome,TUBA4A
Developmental Biology,R-HSA-1266738,reactome,RELN
Developmental Biology,R-HSA-1266738,reactome,PAK3
Developmental Biology,R-HSA-1266738,reactome,CACNA1C
Developmental Biology,R-HSA-1266738,reactome,DLG4
Developmental Biology,R-HSA-1266738,reactome,SCN3A
Developmental Biology,R-HSA-1266738,reactome,EGF
Developmental Biology,R-HSA-1266738,reactome,IL17RD
Developmental Biology,R-HSA-1266738,reactome,DUSP16
Developmental Biology,R-HSA-1266738,reactome,LAMA1
Developmental Biology,R-HSA-1266738,reactome,SCN7A
Developmental Biology,R-HSA-1266738,reactome,TRPC1
Activation of Ca-permeable Kainate Receptor,R-HSA-451308,reactome,DLG4
Extracellular matrix organization,R-HSA-1474244,reactome,ITGA3
Extracellular matrix organization,R-HSA-1474244,reactome,TGFB2
Extracellular matrix organization,R-HSA-1474244,reactome,CAPN5
Extracellular matrix organization,R-HSA-1474244,reactome,COL4A6
Extracellular matrix organization,R-HSA-1474244,reactome,MMP16
Extracellular matrix organization,R-HSA-1474244,reactome,LEPREL1
Extracellular matrix organization,R-HSA-1474244,reactome,TNC
Extracellular matrix organization,R-HSA-1474244,reactome,LAMA1
Extracellular matrix organization,R-HSA-1474244,reactome,PDGFA
Extracellular matrix organization,R-HSA-1474244,reactome,ACTN1
Organic anion transporters,R-HSA-428643,reactome,SLC17A7
Gap junction trafficking and regulation,R-HSA-157858,reactome,TUBA4A
B-WICH complex positively regulates rRNA expression,R-HSA-5250924,reactome,POLR1B
Chaperonin-mediated protein folding,R-HSA-390466,reactome,GNB5
Chaperonin-mediated protein folding,R-HSA-390466,reactome,USP11
Chaperonin-mediated protein folding,R-HSA-390466,reactome,GNG7
Chaperonin-mediated protein folding,R-HSA-390466,reactome,TUBA4A
Regulated proteolysis of p75NTR,R-HSA-193692,reactome,NGFR
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108,reactome,BHLHE40
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108,reactome,NPAS2
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108,reactome,CRY1
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108,reactome,CRY2
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108,reactome,PER2
Metabolism of nucleotides,R-HSA-15869,reactome,NT5C2
Metabolism of nucleotides,R-HSA-15869,reactome,AK5
Rho GTPase cycle,R-HSA-194840,reactome,RHOJ
Thrombin signalling through proteinase activated receptors (PARs),R-HSA-456926,reactome,F2R
Thrombin signalling through proteinase activated receptors (PARs),R-HSA-456926,reactome,GNG7
Thrombin signalling through proteinase activated receptors (PARs),R-HSA-456926,reactome,GNB5
Prefoldin mediated transfer of substrate  to CCT/TriC,R-HSA-389957,reactome,TUBA4A
Toll Like Receptor 10 (TLR10) Cascade,R-HSA-168142,reactome,IRAK2
TNFs bind their physiological receptors,R-HSA-5669034,reactome,TNFRSF11B
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,CACNA1G
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,CACNB2
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,CACNB1
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,DUSP5
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,DUSP16
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,NRG1
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,IL17RD
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,DLG4
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,EGF
NCAM signaling for neurite out-growth,R-HSA-375165,reactome,CACNA1C
G-protein activation,R-HSA-202040,reactome,GNG7
G-protein activation,R-HSA-202040,reactome,GNB5
Neurotoxicity of clostridium toxins,R-HSA-168799,reactome,SV2A
CD28 dependent Vav1 pathway,R-HSA-389359,reactome,PAK3
Uptake and actions of bacterial toxins,R-HSA-5339562,reactome,SV2A
Mitotic G2-G2/M phases,R-HSA-453274,reactome,TUBA4A
CD209 (DC-SIGN) signaling,R-HSA-5621575,reactome,PAK3
Peptide hormone metabolism,R-HSA-2980736,reactome,MYRIP
Peptide hormone metabolism,R-HSA-2980736,reactome,ANPEP
Intra-Golgi and retrograde Golgi-to-ER traffic,R-HSA-6811442,reactome,TUBA4A
Aquaporin-mediated transport,R-HSA-445717,reactome,GNG7
Aquaporin-mediated transport,R-HSA-445717,reactome,GNB5
Abacavir transport and metabolism,R-HSA-2161522,reactome,NT5C2
Abacavir transport and metabolism,R-HSA-2161522,reactome,ABCB1
Transcriptional Regulation by TP53,R-HSA-3700989,reactome,TP63
Transcriptional Regulation by TP53,R-HSA-3700989,reactome,TNFRSF10B
Transcriptional Regulation by TP53,R-HSA-3700989,reactome,YWHAQ
Ubiquitin-dependent degradation of Cyclin D1,R-HSA-69229,reactome,CDK4
SCF(Skp2)-mediated degradation of p27/p21,R-HSA-187577,reactome,CDK4
RHO GTPases activate IQGAPs,R-HSA-5626467,reactome,TUBA4A
Organic cation transport,R-HSA-549127,reactome,SLC22A4
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),R-HSA-975957,reactome,EIF4A3
tRNA Aminoacylation,R-HSA-379724,reactome,LARS
tRNA Aminoacylation,R-HSA-379724,reactome,AARS2
tRNA processing,R-HSA-72306,reactome,TRIT1
tRNA processing,R-HSA-72306,reactome,TRMT11
Gap junction assembly,R-HSA-190861,reactome,TUBA4A
SUMOylation of DNA damage response and repair proteins,R-HSA-3108214,reactome,PIAS1
Cargo recognition for clathrin-mediated endocytosis,R-HSA-8856825,reactome,EGF
Glycerophospholipid catabolism,R-HSA-6814848,reactome,PNPLA7
Platelet Aggregation (Plug Formation),R-HSA-76009,reactome,ADRA2A
MAPK family signaling cascades,R-HSA-5683057,reactome,IL17RD
MAPK family signaling cascades,R-HSA-5683057,reactome,PAK3
MAPK family signaling cascades,R-HSA-5683057,reactome,NRG1
MAPK family signaling cascades,R-HSA-5683057,reactome,EGF
MAPK family signaling cascades,R-HSA-5683057,reactome,CDC14A
MAPK family signaling cascades,R-HSA-5683057,reactome,DLG4
MAPK family signaling cascades,R-HSA-5683057,reactome,DUSP16
MAPK family signaling cascades,R-HSA-5683057,reactome,DUSP5
Non-integrin membrane-ECM interactions,R-HSA-3000171,reactome,LAMA1
Non-integrin membrane-ECM interactions,R-HSA-3000171,reactome,ACTN1
Non-integrin membrane-ECM interactions,R-HSA-3000171,reactome,PDGFA
Non-integrin membrane-ECM interactions,R-HSA-3000171,reactome,COL4A6
Non-integrin membrane-ECM interactions,R-HSA-3000171,reactome,TNC
COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-6811434,reactome,TUBA4A
mitochondrial fatty acid beta-oxidation of saturated fatty acids,R-HSA-77286,reactome,ACSM3
mitochondrial fatty acid beta-oxidation of saturated fatty acids,R-HSA-77286,reactome,ACADS
p75NTR signals via NF-kB,R-HSA-193639,reactome,NGFR
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),R-HSA-400206,reactome,NPAS2
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),R-HSA-400206,reactome,FHL2
Formation of Fibrin Clot (Clotting Cascade),R-HSA-140877,reactome,F2R
Formation of Fibrin Clot (Clotting Cascade),R-HSA-140877,reactome,THBD
Cell Cycle Checkpoints,R-HSA-69620,reactome,YWHAQ
Abacavir transmembrane transport,R-HSA-2161517,reactome,ABCB1
Interferon gamma signaling,R-HSA-877300,reactome,PIAS1
Death Receptor Signalling,R-HSA-73887,reactome,TNFRSF10B
Downstream signal transduction,R-HSA-186763,reactome,IER3
Downstream signal transduction,R-HSA-186763,reactome,EGF
Downstream signal transduction,R-HSA-186763,reactome,PIP5K1A
Downstream signal transduction,R-HSA-186763,reactome,IL17RD
Downstream signal transduction,R-HSA-186763,reactome,DUSP16
Downstream signal transduction,R-HSA-186763,reactome,NRG1
Downstream signal transduction,R-HSA-186763,reactome,DUSP5
Downstream signal transduction,R-HSA-186763,reactome,DLG4
PI3K events in ERBB2 signaling,R-HSA-1963642,reactome,EGF
PI3K events in ERBB2 signaling,R-HSA-1963642,reactome,NRG1
Metabolism of proteins,R-HSA-392499,reactome,PNPLA2
Metabolism of proteins,R-HSA-392499,reactome,GNB5
Metabolism of proteins,R-HSA-392499,reactome,SMURF2
Metabolism of proteins,R-HSA-392499,reactome,ADRA2A
Metabolism of proteins,R-HSA-392499,reactome,LARS
Metabolism of proteins,R-HSA-392499,reactome,GNG7
Metabolism of proteins,R-HSA-392499,reactome,ASNS
Metabolism of proteins,R-HSA-392499,reactome,TNC
Metabolism of proteins,R-HSA-392499,reactome,IGFBP4
Metabolism of proteins,R-HSA-392499,reactome,GALNT10
Metabolism of proteins,R-HSA-392499,reactome,ALG13
Metabolism of proteins,R-HSA-392499,reactome,ANPEP
Metabolism of proteins,R-HSA-392499,reactome,C4A
Metabolism of proteins,R-HSA-392499,reactome,MYRIP
Metabolism of proteins,R-HSA-392499,reactome,AARS2
Metabolism of proteins,R-HSA-392499,reactome,UBE2Z
Metabolism of proteins,R-HSA-392499,reactome,STC2
Metabolism of proteins,R-HSA-392499,reactome,TUBA4A
Metabolism of proteins,R-HSA-392499,reactome,USP22
Metabolism of proteins,R-HSA-392499,reactome,USP11
Metabolism of proteins,R-HSA-392499,reactome,PIGL
Metabolism of proteins,R-HSA-392499,reactome,PIAS1
Signaling by EGFRvIII in Cancer,R-HSA-5637812,reactome,EGF
Toxicity of botulinum toxin type A (BoNT/A),R-HSA-5250968,reactome,SV2A
Collagen formation,R-HSA-1474290,reactome,LEPREL1
Collagen formation,R-HSA-1474290,reactome,COL4A6
Hemostasis,R-HSA-109582,reactome,F2R
Hemostasis,R-HSA-109582,reactome,DOCK5
Hemostasis,R-HSA-109582,reactome,TNFRSF10B
Hemostasis,R-HSA-109582,reactome,MAFF
Hemostasis,R-HSA-109582,reactome,KCNMB1
Hemostasis,R-HSA-109582,reactome,ACTN1
Hemostasis,R-HSA-109582,reactome,DGKA
Hemostasis,R-HSA-109582,reactome,TGFB2
Hemostasis,R-HSA-109582,reactome,TUBA4A
Hemostasis,R-HSA-109582,reactome,EGF
Hemostasis,R-HSA-109582,reactome,THBD
Hemostasis,R-HSA-109582,reactome,EHD2
Hemostasis,R-HSA-109582,reactome,GNG7
Hemostasis,R-HSA-109582,reactome,GNB5
Hemostasis,R-HSA-109582,reactome,ADRA2A
Hemostasis,R-HSA-109582,reactome,ITGA3
Hemostasis,R-HSA-109582,reactome,KCNMA1
Hedgehog 'off' state,R-HSA-5610787,reactome,GLI3
Hedgehog 'off' state,R-HSA-5610787,reactome,GLI2
Hedgehog 'off' state,R-HSA-5610787,reactome,TUBA4A
Prolonged ERK activation events,R-HSA-169893,reactome,DUSP16
Prolonged ERK activation events,R-HSA-169893,reactome,DLG4
Prolonged ERK activation events,R-HSA-169893,reactome,DUSP5
Prolonged ERK activation events,R-HSA-169893,reactome,IL17RD
Prolonged ERK activation events,R-HSA-169893,reactome,EGF
Prolonged ERK activation events,R-HSA-169893,reactome,NRG1
Deubiquitination,R-HSA-5688426,reactome,USP11
Deubiquitination,R-HSA-5688426,reactome,USP22
Deubiquitination,R-HSA-5688426,reactome,SMURF2
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,R-HSA-3772470,reactome,LRP6
Generic Transcription Pathway,R-HSA-212436,reactome,SMURF2
Generic Transcription Pathway,R-HSA-212436,reactome,TP63
Generic Transcription Pathway,R-HSA-212436,reactome,NR4A3
Generic Transcription Pathway,R-HSA-212436,reactome,YWHAQ
Generic Transcription Pathway,R-HSA-212436,reactome,TNFRSF10B
Generic Transcription Pathway,R-HSA-212436,reactome,LIFR
Formation of tubulin folding intermediates by CCT/TriC,R-HSA-389960,reactome,TUBA4A
Nonsense-Mediated Decay (NMD),R-HSA-927802,reactome,EIF4A3
RHO GTPases activate PAKs,R-HSA-5627123,reactome,PAK3
RHO GTPases activate PAKs,R-HSA-5627123,reactome,MYLK
COPI-independent Golgi-to-ER retrograde traffic,R-HSA-6811436,reactome,TUBA4A
SeMet incorporation into proteins,R-HSA-2408517,reactome,LARS
Synthesis of PIPs at the Golgi membrane,R-HSA-1660514,reactome,PIK3C2G
Metabolism of lipids,R-HSA-556833,reactome,PNPLA7
Metabolism of lipids,R-HSA-556833,reactome,FHL2
Metabolism of lipids,R-HSA-556833,reactome,ACSM3
Metabolism of lipids,R-HSA-556833,reactome,PIP5K1A
Metabolism of lipids,R-HSA-556833,reactome,ACOT2
Metabolism of lipids,R-HSA-556833,reactome,PNPLA2
Metabolism of lipids,R-HSA-556833,reactome,NPAS2
Metabolism of lipids,R-HSA-556833,reactome,PPT2
Metabolism of lipids,R-HSA-556833,reactome,SLC44A1
Metabolism of lipids,R-HSA-556833,reactome,ABCC3
Metabolism of lipids,R-HSA-556833,reactome,PIK3C2G
Metabolism of lipids,R-HSA-556833,reactome,ACADS
Metabolism of lipids,R-HSA-556833,reactome,SCD5
Metabolism of lipids,R-HSA-556833,reactome,LIPE
Metabolism of lipids,R-HSA-556833,reactome,SGPP1
TCR signaling,R-HSA-202403,reactome,PAK3
Asymmetric localization of PCP proteins,R-HSA-4608870,reactome,SMURF2
ERBB2 Activates PTK6 Signaling,R-HSA-8847993,reactome,EGF
ERBB2 Activates PTK6 Signaling,R-HSA-8847993,reactome,NRG1
Golgi-to-ER retrograde transport,R-HSA-8856688,reactome,TUBA4A
mRNA Splicing - Major Pathway,R-HSA-72163,reactome,SF3B3
mRNA Splicing - Major Pathway,R-HSA-72163,reactome,EIF4A3
RNA Polymerase II Transcription,R-HSA-73857,reactome,EIF4A3
RNA Polymerase II Transcription,R-HSA-73857,reactome,TP63
RNA Polymerase II Transcription,R-HSA-73857,reactome,YWHAQ
RNA Polymerase II Transcription,R-HSA-73857,reactome,NR4A3
RNA Polymerase II Transcription,R-HSA-73857,reactome,SMURF2
RNA Polymerase II Transcription,R-HSA-73857,reactome,LIFR
RNA Polymerase II Transcription,R-HSA-73857,reactome,TNFRSF10B
Basigin interactions,R-HSA-210991,reactome,ITGA3
TGF-beta receptor signaling activates SMADs,R-HSA-2173789,reactome,SMURF2
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-6814122,reactome,GNB5
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-6814122,reactome,GNG7
Interleukin-17 signaling,R-HSA-448424,reactome,DUSP5
Interleukin-17 signaling,R-HSA-448424,reactome,NRG1
Interleukin-17 signaling,R-HSA-448424,reactome,DLG4
Interleukin-17 signaling,R-HSA-448424,reactome,IRAK2
Interleukin-17 signaling,R-HSA-448424,reactome,DUSP16
Interleukin-17 signaling,R-HSA-448424,reactome,IL17RD
Interleukin-17 signaling,R-HSA-448424,reactome,EGF
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558,reactome,NRG1
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558,reactome,IER3
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558,reactome,EGF
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558,reactome,PIP5K1A
Negative epigenetic regulation of rRNA expression,R-HSA-5250941,reactome,POLR1B
Surfactant metabolism,R-HSA-5683826,reactome,ADRA2A
Transport of Mature mRNA Derived from an Intronless Transcript,R-HSA-159231,reactome,NXF1
Signaling by Rho GTPases,R-HSA-194315,reactome,PAK3
Signaling by Rho GTPases,R-HSA-194315,reactome,RHOJ
Signaling by Rho GTPases,R-HSA-194315,reactome,MYLK
Signaling by Rho GTPases,R-HSA-194315,reactome,TUBA4A
Signaling by Rho GTPases,R-HSA-194315,reactome,DLG4
Signaling by Rho GTPases,R-HSA-194315,reactome,YWHAQ
Response to elevated platelet cytosolic Ca2+,R-HSA-76005,reactome,EGF
Response to elevated platelet cytosolic Ca2+,R-HSA-76005,reactome,ACTN1
Response to elevated platelet cytosolic Ca2+,R-HSA-76005,reactome,TUBA4A
Response to elevated platelet cytosolic Ca2+,R-HSA-76005,reactome,TGFB2
Adrenoceptors,R-HSA-390696,reactome,ADRA2A
Regulation by c-FLIP,R-HSA-3371378,reactome,TNFRSF10B
Downregulation of SMAD2/3:SMAD4 transcriptional activity,R-HSA-2173795,reactome,SMURF2
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,R-HSA-6803205,reactome,TP63
Downregulation of TGF-beta receptor signaling,R-HSA-2173788,reactome,SMURF2
Signaling by MET,R-HSA-6806834,reactome,LAMA1
Signaling by MET,R-HSA-6806834,reactome,ITGA3
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,NRG1
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,DLG4
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,EGF
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,DUSP16
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,DUSP5
VEGFR2 mediated cell proliferation,R-HSA-5218921,reactome,IL17RD
activated TAK1 mediates p38 MAPK activation,R-HSA-450302,reactome,IRAK2
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,R-HSA-8866652,reactome,UBE2Z
Antigen processing: Ubiquitination & Proteasome degradation,R-HSA-983168,reactome,UBE2Z
Antigen processing: Ubiquitination & Proteasome degradation,R-HSA-983168,reactome,SMURF2
Signaling by Robo receptor,R-HSA-376176,reactome,PAK3
Cell-extracellular matrix interactions,R-HSA-446353,reactome,ACTN1
RNF mutants show enhanced WNT signaling and proliferation,R-HSA-5340588,reactome,LRP6
Activation of Rac,R-HSA-428540,reactome,PAK3
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",R-HSA-5140745,reactome,ROR2
LGI-ADAM interactions,R-HSA-5682910,reactome,DLG4
Resolution of Sister Chromatid Cohesion,R-HSA-2500257,reactome,TUBA4A
Cellular responses to stress,R-HSA-2262752,reactome,TUBA4A
Cellular responses to stress,R-HSA-2262752,reactome,CDK4
O-linked glycosylation,R-HSA-5173105,reactome,GALNT10
Interaction between L1 and Ankyrins,R-HSA-445095,reactome,SCN7A
Interaction between L1 and Ankyrins,R-HSA-445095,reactome,SCN3A
RET signaling,R-HSA-8853659,reactome,DUSP16
RET signaling,R-HSA-8853659,reactome,DLG4
RET signaling,R-HSA-8853659,reactome,NRG1
RET signaling,R-HSA-8853659,reactome,IL17RD
RET signaling,R-HSA-8853659,reactome,EGF
RET signaling,R-HSA-8853659,reactome,DUSP5
TP53 Regulates Transcription of Death Receptors and Ligands,R-HSA-6803211,reactome,TNFRSF10B
TP53 Regulates Transcription of Death Receptors and Ligands,R-HSA-6803211,reactome,TP63
Frs2-mediated activation,R-HSA-170968,reactome,DUSP16
Frs2-mediated activation,R-HSA-170968,reactome,EGF
Frs2-mediated activation,R-HSA-170968,reactome,NRG1
Frs2-mediated activation,R-HSA-170968,reactome,IL17RD
Frs2-mediated activation,R-HSA-170968,reactome,DUSP5
Frs2-mediated activation,R-HSA-170968,reactome,DLG4
Regulation of FZD by ubiquitination,R-HSA-4641263,reactome,LRP6
Activation of PUMA and translocation to mitochondria,R-HSA-139915,reactome,TP63
Integration of energy metabolism,R-HSA-163685,reactome,CACNA1C
Integration of energy metabolism,R-HSA-163685,reactome,CACNB2
Integration of energy metabolism,R-HSA-163685,reactome,ADRA2A
Integration of energy metabolism,R-HSA-163685,reactome,GNG7
Integration of energy metabolism,R-HSA-163685,reactome,GNB5
Signaling by Overexpressed Wild-Type EGFR in Cancer,R-HSA-5638302,reactome,EGF
DNA Repair,R-HSA-73894,reactome,PIAS1
RAF/MAP kinase cascade,R-HSA-5673001,reactome,DUSP5
RAF/MAP kinase cascade,R-HSA-5673001,reactome,NRG1
RAF/MAP kinase cascade,R-HSA-5673001,reactome,EGF
RAF/MAP kinase cascade,R-HSA-5673001,reactome,DUSP16
RAF/MAP kinase cascade,R-HSA-5673001,reactome,DLG4
RAF/MAP kinase cascade,R-HSA-5673001,reactome,IL17RD
rRNA processing,R-HSA-72312,reactome,FBL
GLI3 is processed to GLI3R by the proteasome,R-HSA-5610785,reactome,GLI3
Signaling by PDGF,R-HSA-186797,reactome,NRG1
Signaling by PDGF,R-HSA-186797,reactome,DUSP16
Signaling by PDGF,R-HSA-186797,reactome,DLG4
Signaling by PDGF,R-HSA-186797,reactome,EGF
Signaling by PDGF,R-HSA-186797,reactome,DUSP5
Signaling by PDGF,R-HSA-186797,reactome,IL17RD
Signaling by PDGF,R-HSA-186797,reactome,PIP5K1A
Signaling by PDGF,R-HSA-186797,reactome,IER3
Olfactory Signaling Pathway,R-HSA-381753,reactome,OR2A4
Degradation of the extracellular matrix,R-HSA-1474228,reactome,COL4A6
Degradation of the extracellular matrix,R-HSA-1474228,reactome,MMP16
Degradation of the extracellular matrix,R-HSA-1474228,reactome,CAPN5
Initial triggering of complement,R-HSA-166663,reactome,C4A
Platelet homeostasis,R-HSA-418346,reactome,GNB5
Platelet homeostasis,R-HSA-418346,reactome,KCNMB1
Platelet homeostasis,R-HSA-418346,reactome,GNG7
Platelet homeostasis,R-HSA-418346,reactome,KCNMA1
Anchoring of the basal body to the plasma membrane,R-HSA-5620912,reactome,TUBA4A
CD28 co-stimulation,R-HSA-389356,reactome,PAK3
Signaling by PTK6,R-HSA-8848021,reactome,NRG1
Signaling by PTK6,R-HSA-8848021,reactome,CDK4
Signaling by PTK6,R-HSA-8848021,reactome,EGF
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,NRG1
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,DUSP16
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,IGF1R
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,DLG4
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,DUSP5
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,EGF
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192,reactome,IL17RD
Hyaluronan uptake and degradation,R-HSA-2160916,reactome,STAB2
Hyaluronan uptake and degradation,R-HSA-2160916,reactome,SLC9A1
Asparagine N-linked glycosylation,R-HSA-446203,reactome,TUBA4A
Asparagine N-linked glycosylation,R-HSA-446203,reactome,ALG13
EPH-Ephrin signaling,R-HSA-2682334,reactome,PAK3
Muscle contraction,R-HSA-397014,reactome,CACNB2
Muscle contraction,R-HSA-397014,reactome,TRPC1
Muscle contraction,R-HSA-397014,reactome,CASQ2
Muscle contraction,R-HSA-397014,reactome,TPM4
Muscle contraction,R-HSA-397014,reactome,CACNB1
Muscle contraction,R-HSA-397014,reactome,ACTA2
Muscle contraction,R-HSA-397014,reactome,KCNIP1
Muscle contraction,R-HSA-397014,reactome,CACNA2D1
Muscle contraction,R-HSA-397014,reactome,KCNIP2
Muscle contraction,R-HSA-397014,reactome,MYLK
Muscle contraction,R-HSA-397014,reactome,DES
Muscle contraction,R-HSA-397014,reactome,CACNA1C
Muscle contraction,R-HSA-397014,reactome,SCN3A
Muscle contraction,R-HSA-397014,reactome,SCN7A
Muscle contraction,R-HSA-397014,reactome,ATP1A2
Netrin-1 signaling,R-HSA-373752,reactome,TRPC1
Metabolism of amino acids and derivatives,R-HSA-71291,reactome,ASNS
Metabolism of amino acids and derivatives,R-HSA-71291,reactome,BHMT2
Metabolism of amino acids and derivatives,R-HSA-71291,reactome,LARS
Metabolism of amino acids and derivatives,R-HSA-71291,reactome,SLC44A1
Metabolism of amino acids and derivatives,R-HSA-71291,reactome,DMGDH
Signalling to RAS,R-HSA-167044,reactome,IL17RD
Signalling to RAS,R-HSA-167044,reactome,NRG1
Signalling to RAS,R-HSA-167044,reactome,EGF
Signalling to RAS,R-HSA-167044,reactome,DLG4
Signalling to RAS,R-HSA-167044,reactome,DUSP16
Signalling to RAS,R-HSA-167044,reactome,DUSP5
Glucagon-type ligand receptors,R-HSA-420092,reactome,VIPR2
Glucagon-type ligand receptors,R-HSA-420092,reactome,GNG7
Glucagon-type ligand receptors,R-HSA-420092,reactome,GNB5
Anchoring fibril formation,R-HSA-2214320,reactome,COL4A6
Toll Like Receptor 9 (TLR9) Cascade,R-HSA-168138,reactome,IRAK2
PIP3 activates AKT signaling,R-HSA-1257604,reactome,PIP5K1A
PIP3 activates AKT signaling,R-HSA-1257604,reactome,EGF
PIP3 activates AKT signaling,R-HSA-1257604,reactome,NRG1
PIP3 activates AKT signaling,R-HSA-1257604,reactome,IER3
Senescence-Associated Secretory Phenotype (SASP),R-HSA-2559582,reactome,CDK4
TRAF6 mediated induction of TAK1 complex,R-HSA-937072,reactome,IRAK2
Cell-cell junction organization,R-HSA-421270,reactome,CLDN11
TNFR2 non-canonical NF-kB pathway,R-HSA-5668541,reactome,TNFRSF11B
Selenoamino acid metabolism,R-HSA-2408522,reactome,LARS
Signaling by GPCR,R-HSA-372790,reactome,PTGER3
Signaling by GPCR,R-HSA-372790,reactome,OR2A4
Signaling by GPCR,R-HSA-372790,reactome,GNB5
Signaling by GPCR,R-HSA-372790,reactome,GNG7
Signaling by GPCR,R-HSA-372790,reactome,PLCB4
Signaling by GPCR,R-HSA-372790,reactome,GRPR
Signaling by GPCR,R-HSA-372790,reactome,F2R
Signaling by GPCR,R-HSA-372790,reactome,IL17RD
Signaling by GPCR,R-HSA-372790,reactome,OXTR
Signaling by GPCR,R-HSA-372790,reactome,DUSP16
Signaling by GPCR,R-HSA-372790,reactome,NRG1
Signaling by GPCR,R-HSA-372790,reactome,DGKA
Signaling by GPCR,R-HSA-372790,reactome,ADRA2A
Signaling by GPCR,R-HSA-372790,reactome,VIPR2
Signaling by GPCR,R-HSA-372790,reactome,LPPR2
Signaling by GPCR,R-HSA-372790,reactome,DUSP5
Signaling by GPCR,R-HSA-372790,reactome,PROK1
Signaling by GPCR,R-HSA-372790,reactome,DLG4
Signaling by GPCR,R-HSA-372790,reactome,EGF
Transport of the SLBP independent Mature mRNA,R-HSA-159227,reactome,NXF1
Signaling by Ligand-Responsive EGFR Variants in Cancer,R-HSA-5637815,reactome,EGF
Synaptic adhesion-like molecules,R-HSA-8849932,reactome,GRIA4
Synaptic adhesion-like molecules,R-HSA-8849932,reactome,DLG4
Toxicity of botulinum toxin type D (BoNT/D),R-HSA-5250955,reactome,SV2A
MyD88-independent TLR3/TLR4 cascade ,R-HSA-166166,reactome,IRAK2
Signaling by Hedgehog,R-HSA-5358351,reactome,SMURF2
Signaling by Hedgehog,R-HSA-5358351,reactome,TUBA4A
Signaling by Hedgehog,R-HSA-5358351,reactome,GLI2
Signaling by Hedgehog,R-HSA-5358351,reactome,GLI3
Signaling by Leptin,R-HSA-2586552,reactome,NRG1
Signaling by Leptin,R-HSA-2586552,reactome,DUSP5
Signaling by Leptin,R-HSA-2586552,reactome,EGF
Signaling by Leptin,R-HSA-2586552,reactome,DUSP16
Signaling by Leptin,R-HSA-2586552,reactome,DLG4
Signaling by Leptin,R-HSA-2586552,reactome,IL17RD
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,R-HSA-389958,reactome,TUBA4A
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,R-HSA-446388,reactome,ACTN1
Glycosaminoglycan metabolism,R-HSA-1630316,reactome,CHSY1
Glycosaminoglycan metabolism,R-HSA-1630316,reactome,SLC9A1
Glycosaminoglycan metabolism,R-HSA-1630316,reactome,STAB2
Glycosaminoglycan metabolism,R-HSA-1630316,reactome,HS6ST1
Glycosaminoglycan metabolism,R-HSA-1630316,reactome,HPSE2
Striated Muscle Contraction,R-HSA-390522,reactome,DES
Striated Muscle Contraction,R-HSA-390522,reactome,TPM4
Ub-specific processing proteases,R-HSA-5689880,reactome,USP11
Ub-specific processing proteases,R-HSA-5689880,reactome,USP22
Ub-specific processing proteases,R-HSA-5689880,reactome,SMURF2
Role of LAT2/NTAL/LAB on calcium mobilization,R-HSA-2730905,reactome,NRG1
Role of LAT2/NTAL/LAB on calcium mobilization,R-HSA-2730905,reactome,IER3
Role of LAT2/NTAL/LAB on calcium mobilization,R-HSA-2730905,reactome,EGF
Role of LAT2/NTAL/LAB on calcium mobilization,R-HSA-2730905,reactome,PIP5K1A
Costimulation by the CD28 family,R-HSA-388841,reactome,PAK3
Chromatin modifying enzymes,R-HSA-3247509,reactome,CDK4
Chromatin modifying enzymes,R-HSA-3247509,reactome,USP22
Opioid Signalling,R-HSA-111885,reactome,GNG7
Opioid Signalling,R-HSA-111885,reactome,PLCB4
Opioid Signalling,R-HSA-111885,reactome,GNB5
Nephrin family interactions,R-HSA-373753,reactome,ACTN1
Cell junction organization,R-HSA-446728,reactome,ACTN1
Cell junction organization,R-HSA-446728,reactome,CLDN11
Cell junction organization,R-HSA-446728,reactome,KRT14
Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393,reactome,SLC7A1
Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393,reactome,SLC17A7
Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393,reactome,SLC9A1
Cytosolic tRNA aminoacylation,R-HSA-379716,reactome,LARS
Activation of NMDA receptor and postsynaptic events,R-HSA-442755,reactome,DLG4
Activation of NMDA receptor and postsynaptic events,R-HSA-442755,reactome,GRIA4
GRB2 events in ERBB2 signaling,R-HSA-1963640,reactome,EGF
GRB2 events in ERBB2 signaling,R-HSA-1963640,reactome,NRG1
Amine ligand-binding receptors,R-HSA-375280,reactome,ADRA2A
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,R-HSA-381676,reactome,GNB5
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,R-HSA-381676,reactome,GNG7
Nucleotide Excision Repair,R-HSA-5696398,reactome,PIAS1
Oxidative Stress Induced Senescence,R-HSA-2559580,reactome,CDK4
GPCR downstream signaling,R-HSA-388396,reactome,PROK1
GPCR downstream signaling,R-HSA-388396,reactome,GNG7
GPCR downstream signaling,R-HSA-388396,reactome,GRPR
GPCR downstream signaling,R-HSA-388396,reactome,OR2A4
GPCR downstream signaling,R-HSA-388396,reactome,OXTR
GPCR downstream signaling,R-HSA-388396,reactome,F2R
GPCR downstream signaling,R-HSA-388396,reactome,PLCB4
GPCR downstream signaling,R-HSA-388396,reactome,VIPR2
GPCR downstream signaling,R-HSA-388396,reactome,PTGER3
GPCR downstream signaling,R-HSA-388396,reactome,GNB5
GPCR downstream signaling,R-HSA-388396,reactome,DGKA
GPCR downstream signaling,R-HSA-388396,reactome,ADRA2A
Signaling by Interleukins,R-HSA-449147,reactome,IRAK2
Signaling by Interleukins,R-HSA-449147,reactome,NRG1
Signaling by Interleukins,R-HSA-449147,reactome,IER3
Signaling by Interleukins,R-HSA-449147,reactome,DUSP5
Signaling by Interleukins,R-HSA-449147,reactome,DLG4
Signaling by Interleukins,R-HSA-449147,reactome,LIF
Signaling by Interleukins,R-HSA-449147,reactome,EGF
Signaling by Interleukins,R-HSA-449147,reactome,IL4R
Signaling by Interleukins,R-HSA-449147,reactome,DUSP16
Signaling by Interleukins,R-HSA-449147,reactome,PIP5K1A
Signaling by Interleukins,R-HSA-449147,reactome,LIFR
Signaling by Interleukins,R-HSA-449147,reactome,IL17RD
ISG15 antiviral mechanism,R-HSA-1169408,reactome,EIF4A3
G2/M Checkpoints,R-HSA-69481,reactome,YWHAQ
p75NTR negatively regulates cell cycle via SC1,R-HSA-193670,reactome,NGFR
Class B/2 (Secretin family receptors),R-HSA-373080,reactome,GNB5
Class B/2 (Secretin family receptors),R-HSA-373080,reactome,GNG7
Class B/2 (Secretin family receptors),R-HSA-373080,reactome,VIPR2
Glycerophospholipid biosynthesis,R-HSA-1483206,reactome,PNPLA2
Glycerophospholipid biosynthesis,R-HSA-1483206,reactome,SLC44A1
Ion channel transport,R-HSA-983712,reactome,TRPC1
Ion channel transport,R-HSA-983712,reactome,ATP8B2
Ion channel transport,R-HSA-983712,reactome,TRPM3
Ion channel transport,R-HSA-983712,reactome,ATP9B
Ion channel transport,R-HSA-983712,reactome,ATP10D
Ion channel transport,R-HSA-983712,reactome,CASQ2
Ion channel transport,R-HSA-983712,reactome,ATP1A2
Signaling by TGF-beta Receptor Complex,R-HSA-170834,reactome,SMURF2
Transport of organic anions,R-HSA-879518,reactome,SLCO2A1
Elastic fibre formation,R-HSA-1566948,reactome,TGFB2
Cellular hexose transport,R-HSA-189200,reactome,SLC2A12
ABC-family proteins mediated transport,R-HSA-382556,reactome,ABCB1
ABC-family proteins mediated transport,R-HSA-382556,reactome,ABCC3
Beta-catenin independent WNT signaling,R-HSA-3858494,reactome,ROR2
Beta-catenin independent WNT signaling,R-HSA-3858494,reactome,GNB5
Beta-catenin independent WNT signaling,R-HSA-3858494,reactome,GNG7
Beta-catenin independent WNT signaling,R-HSA-3858494,reactome,SMURF2
Reelin signalling pathway,R-HSA-8866376,reactome,RELN
MyD88:Mal cascade initiated on plasma membrane,R-HSA-166058,reactome,IRAK2
Constitutive Signaling by Aberrant PI3K in Cancer,R-HSA-2219530,reactome,EGF
Constitutive Signaling by Aberrant PI3K in Cancer,R-HSA-2219530,reactome,NRG1
PLC beta mediated events,R-HSA-112043,reactome,PLCB4
Ligand-dependent caspase activation,R-HSA-140534,reactome,TNFRSF10B
Trafficking of GluR2-containing AMPA receptors,R-HSA-416993,reactome,GRIA4
Clathrin-mediated endocytosis,R-HSA-8856828,reactome,EGF
G beta:gamma signalling through PI3Kgamma,R-HSA-392451,reactome,GNG7
G beta:gamma signalling through PI3Kgamma,R-HSA-392451,reactome,GNB5
Insulin processing,R-HSA-264876,reactome,MYRIP
Global Genome Nucleotide Excision Repair (GG-NER),R-HSA-5696399,reactome,PIAS1
Eicosanoid ligand-binding receptors,R-HSA-391903,reactome,PTGER3
Chondroitin sulfate biosynthesis,R-HSA-2022870,reactome,CHSY1
Collagen chain trimerization,R-HSA-8948216,reactome,COL4A6
ATF4 activates genes,R-HSA-380994,reactome,ASNS
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,R-HSA-975138,reactome,IRAK2
RAF-independent MAPK1/3 activation,R-HSA-112409,reactome,DUSP16
RAF-independent MAPK1/3 activation,R-HSA-112409,reactome,DUSP5
PLCG1 events in ERBB2 signaling,R-HSA-1251932,reactome,EGF
RNA Polymerase I Promoter Escape,R-HSA-73772,reactome,POLR1B
Role of phospholipids in phagocytosis,R-HSA-2029485,reactome,PPAPDC1B
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,R-HSA-8936459,reactome,NR4A3
Inositol phosphate metabolism,R-HSA-1483249,reactome,PLCB4
Inositol phosphate metabolism,R-HSA-1483249,reactome,INPP1
Inositol phosphate metabolism,R-HSA-1483249,reactome,ISYNA1
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,DUSP5
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,DUSP16
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,EGF
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,IL17RD
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,NRG1
Signalling to p38 via RIT and RIN,R-HSA-187706,reactome,DLG4
Neurotransmitter release cycle,R-HSA-112310,reactome,ABAT
Neurotransmitter release cycle,R-HSA-112310,reactome,SLC17A7
Ubiquitin-dependent degradation of Cyclin D,R-HSA-75815,reactome,CDK4
Recruitment of mitotic centrosome proteins and complexes,R-HSA-380270,reactome,TUBA4A
MyD88 dependent cascade initiated on endosome,R-HSA-975155,reactome,IRAK2
Neurexins and neuroligins,R-HSA-6794361,reactome,DLG4
Deadenylation-dependent mRNA decay,R-HSA-429914,reactome,EIF4A3
Interferon Signaling,R-HSA-913531,reactome,EIF4A3
Interferon Signaling,R-HSA-913531,reactome,PIAS1
Metabolism of Angiotensinogen to Angiotensins,R-HSA-2022377,reactome,ANPEP
Chondroitin sulfate/dermatan sulfate metabolism,R-HSA-1793185,reactome,CHSY1
"Synthesis of IP2, IP, and Ins in the cytosol",R-HSA-1855183,reactome,ISYNA1
"Synthesis of IP2, IP, and Ins in the cytosol",R-HSA-1855183,reactome,INPP1
Phase 1 - inactivation of fast Na+ channels,R-HSA-5576894,reactome,KCNIP1
Phase 1 - inactivation of fast Na+ channels,R-HSA-5576894,reactome,KCNIP2
Lysosphingolipid and LPA receptors,R-HSA-419408,reactome,LPPR2
Transport of small molecules,R-HSA-382551,reactome,CASQ2
Transport of small molecules,R-HSA-382551,reactome,SLC2A12
Transport of small molecules,R-HSA-382551,reactome,ATP8B2
Transport of small molecules,R-HSA-382551,reactome,SLC44A1
Transport of small molecules,R-HSA-382551,reactome,SLCO2A1
Transport of small molecules,R-HSA-382551,reactome,TRPM3
Transport of small molecules,R-HSA-382551,reactome,ATP1A2
Transport of small molecules,R-HSA-382551,reactome,TRPC1
Transport of small molecules,R-HSA-382551,reactome,ABCB1
Transport of small molecules,R-HSA-382551,reactome,ATP9B
Transport of small molecules,R-HSA-382551,reactome,SLC17A7
Transport of small molecules,R-HSA-382551,reactome,SLC7A1
Transport of small molecules,R-HSA-382551,reactome,ABCC3
Transport of small molecules,R-HSA-382551,reactome,SLC22A4
Transport of small molecules,R-HSA-382551,reactome,SLC14A2
Transport of small molecules,R-HSA-382551,reactome,GNG7
Transport of small molecules,R-HSA-382551,reactome,GNB5
Transport of small molecules,R-HSA-382551,reactome,SLC9A1
Transport of small molecules,R-HSA-382551,reactome,ATP10D
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-2173793,reactome,SMURF2
G2/M Transition,R-HSA-69275,reactome,TUBA4A
Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1638091,reactome,HPSE2
Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1638091,reactome,HS6ST1
Glycogen breakdown (glycogenolysis),R-HSA-70221,reactome,PGM2
Glycogen breakdown (glycogenolysis),R-HSA-70221,reactome,PHKG2
Biological oxidations,R-HSA-211859,reactome,GSTM5
Transmission across Chemical Synapses,R-HSA-112315,reactome,GRIA4
Transmission across Chemical Synapses,R-HSA-112315,reactome,DLG4
Transmission across Chemical Synapses,R-HSA-112315,reactome,SLC17A7
Transmission across Chemical Synapses,R-HSA-112315,reactome,CACNB2
Transmission across Chemical Synapses,R-HSA-112315,reactome,GNB5
Transmission across Chemical Synapses,R-HSA-112315,reactome,CACNB1
Transmission across Chemical Synapses,R-HSA-112315,reactome,GNG7
Transmission across Chemical Synapses,R-HSA-112315,reactome,ABAT
Sodium/Proton exchangers,R-HSA-425986,reactome,SLC9A1
Interleukin-1 family signaling,R-HSA-446652,reactome,IRAK2
GAB1 signalosome,R-HSA-180292,reactome,PIP5K1A
GAB1 signalosome,R-HSA-180292,reactome,NRG1
GAB1 signalosome,R-HSA-180292,reactome,IER3
GAB1 signalosome,R-HSA-180292,reactome,EGF
Potassium Channels,R-HSA-1296071,reactome,KCNMA1
Potassium Channels,R-HSA-1296071,reactome,GNG7
Potassium Channels,R-HSA-1296071,reactome,KCNMB1
Ca2+ activated K+ channels,R-HSA-1296052,reactome,KCNMA1
Ca2+ activated K+ channels,R-HSA-1296052,reactome,KCNMB1
Metabolism of carbohydrates,R-HSA-71387,reactome,PGM2
Metabolism of carbohydrates,R-HSA-71387,reactome,PHKG2
Metabolism of carbohydrates,R-HSA-71387,reactome,HS6ST1
Metabolism of carbohydrates,R-HSA-71387,reactome,SLC9A1
Metabolism of carbohydrates,R-HSA-71387,reactome,PFKP
Metabolism of carbohydrates,R-HSA-71387,reactome,CHSY1
Metabolism of carbohydrates,R-HSA-71387,reactome,STAB2
Metabolism of carbohydrates,R-HSA-71387,reactome,HPSE2
Interleukin-7 signaling,R-HSA-1266695,reactome,EGF
Interleukin-7 signaling,R-HSA-1266695,reactome,PIP5K1A
Interleukin-7 signaling,R-HSA-1266695,reactome,NRG1
Interleukin-7 signaling,R-HSA-1266695,reactome,IER3
Nucleobase catabolism,R-HSA-8956319,reactome,NT5C2
Adaptive Immune System,R-HSA-1280218,reactome,PIP5K1A
Adaptive Immune System,R-HSA-1280218,reactome,EGF
Adaptive Immune System,R-HSA-1280218,reactome,PAK3
Adaptive Immune System,R-HSA-1280218,reactome,IER3
Adaptive Immune System,R-HSA-1280218,reactome,TRPC1
Adaptive Immune System,R-HSA-1280218,reactome,NRG1
Adaptive Immune System,R-HSA-1280218,reactome,SMURF2
Adaptive Immune System,R-HSA-1280218,reactome,UBE2Z
Adaptive Immune System,R-HSA-1280218,reactome,TUBA4A
Carboxyterminal post-translational modifications of tubulin,R-HSA-8955332,reactome,TUBA4A
Synthesis of IP3 and IP4 in the cytosol,R-HSA-1855204,reactome,PLCB4
Hyaluronan metabolism,R-HSA-2142845,reactome,STAB2
Hyaluronan metabolism,R-HSA-2142845,reactome,SLC9A1
PERK regulates gene expression,R-HSA-381042,reactome,ASNS
Organelle biogenesis and maintenance,R-HSA-1852241,reactome,TUBA4A
p75NTR regulates axonogenesis,R-HSA-193697,reactome,NGFR
Toxicity of botulinum toxin type F (BoNT/F),R-HSA-5250981,reactome,SV2A
MAP kinase activation in TLR cascade,R-HSA-450294,reactome,IRAK2
tRNA modification in the mitochondrion,R-HSA-6787450,reactome,TRIT1
ADP signalling through P2Y purinoceptor 1,R-HSA-418592,reactome,GNB5
ADP signalling through P2Y purinoceptor 1,R-HSA-418592,reactome,GNG7
PTK6 Regulates Cell Cycle,R-HSA-8849470,reactome,CDK4
Activated TLR4 signalling,R-HSA-166054,reactome,IRAK2
Formation of the cornified envelope,R-HSA-6809371,reactome,DSC1
Formation of the cornified envelope,R-HSA-6809371,reactome,KRT14
NF-kB is activated and signals survival,R-HSA-209560,reactome,NGFR
Amino acid transport across the plasma membrane,R-HSA-352230,reactome,SLC7A1
Post-chaperonin tubulin folding pathway,R-HSA-389977,reactome,TUBA4A
Signaling by Retinoic Acid,R-HSA-5362517,reactome,DHRS3
Signaling by Retinoic Acid,R-HSA-5362517,reactome,ALDH1A2
Loss of proteins required for interphase microtubule organization from the centrosome,R-HSA-380284,reactome,TUBA4A
Fcgamma receptor (FCGR) dependent phagocytosis,R-HSA-2029480,reactome,PPAPDC1B
Metabolism of steroids,R-HSA-8957322,reactome,ABCC3
Scavenging by Class H Receptors,R-HSA-3000497,reactome,STAB2
Degradation of AXIN,R-HSA-4641257,reactome,SMURF2
Sphingolipid de novo biosynthesis,R-HSA-1660661,reactome,SGPP1
Syndecan interactions,R-HSA-3000170,reactome,TNC
Syndecan interactions,R-HSA-3000170,reactome,ACTN1
Cyclin A:Cdk2-associated events at S phase entry,R-HSA-69656,reactome,CDK4
Disassembly of the destruction complex and recruitment of AXIN to the membrane,R-HSA-4641262,reactome,LRP6
Disease,R-HSA-1643685,reactome,LRP6
Disease,R-HSA-1643685,reactome,NRG1
Disease,R-HSA-1643685,reactome,EGF
Disease,R-HSA-1643685,reactome,SV2A
Association of TriC/CCT with target proteins during biosynthesis,R-HSA-390471,reactome,USP11
Ca2+ pathway,R-HSA-4086398,reactome,GNB5
Ca2+ pathway,R-HSA-4086398,reactome,GNG7
NrCAM interactions,R-HSA-447038,reactome,DLG4
Activation of G protein gated Potassium channels,R-HSA-1296041,reactome,GNG7
ERBB2 Regulates Cell Motility,R-HSA-6785631,reactome,EGF
ERBB2 Regulates Cell Motility,R-HSA-6785631,reactome,NRG1
TRIF-mediated TLR3/TLR4 signaling ,R-HSA-937061,reactome,IRAK2
Inwardly rectifying K+ channels,R-HSA-1296065,reactome,GNG7
TCF dependent signaling in response to WNT,R-HSA-201681,reactome,LRP6
TCF dependent signaling in response to WNT,R-HSA-201681,reactome,SMURF2
Meiosis,R-HSA-1500620,reactome,CDK4
Recycling of bile acids and salts,R-HSA-159418,reactome,ABCC3
ECM proteoglycans,R-HSA-3000178,reactome,TGFB2
ECM proteoglycans,R-HSA-3000178,reactome,TNC
ECM proteoglycans,R-HSA-3000178,reactome,LAMA1
ECM proteoglycans,R-HSA-3000178,reactome,COL4A6
RMTs methylate histone arginines,R-HSA-3214858,reactome,CDK4
G-protein beta:gamma signalling,R-HSA-397795,reactome,GNB5
G-protein beta:gamma signalling,R-HSA-397795,reactome,GNG7
Presynaptic function of Kainate receptors,R-HSA-500657,reactome,GNB5
Presynaptic function of Kainate receptors,R-HSA-500657,reactome,GNG7
"Unblocking of NMDA receptor, glutamate binding and activation",R-HSA-438066,reactome,GRIA4
"Unblocking of NMDA receptor, glutamate binding and activation",R-HSA-438066,reactome,DLG4
Assembly of collagen fibrils and other multimeric structures,R-HSA-2022090,reactome,COL4A6
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,EGF
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,DLG4
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,PAK3
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,DUSP16
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,IL17RD
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,NRG1
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,AXL
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,DUSP5
Phase 2 - plateau phase,R-HSA-5576893,reactome,CACNB2
Phase 2 - plateau phase,R-HSA-5576893,reactome,CACNA1C
Phase 2 - plateau phase,R-HSA-5576893,reactome,CACNA2D1
Phase 2 - plateau phase,R-HSA-5576893,reactome,CACNB1
SHC1 events in ERBB4 signaling,R-HSA-1250347,reactome,NRG1
G alpha (12/13) signalling events,R-HSA-416482,reactome,GNB5
G alpha (12/13) signalling events,R-HSA-416482,reactome,GNG7
Signaling by WNT in cancer,R-HSA-4791275,reactome,LRP6
Kinesins,R-HSA-983189,reactome,TUBA4A
Axon guidance,R-HSA-422475,reactome,PAK3
Axon guidance,R-HSA-422475,reactome,CACNA1C
Axon guidance,R-HSA-422475,reactome,NRG1
Axon guidance,R-HSA-422475,reactome,IL17RD
Axon guidance,R-HSA-422475,reactome,CACNB2
Axon guidance,R-HSA-422475,reactome,SCN3A
Axon guidance,R-HSA-422475,reactome,TUBA4A
Axon guidance,R-HSA-422475,reactome,DLG4
Axon guidance,R-HSA-422475,reactome,CACNB1
Axon guidance,R-HSA-422475,reactome,RELN
Axon guidance,R-HSA-422475,reactome,EGF
Axon guidance,R-HSA-422475,reactome,LAMA1
Axon guidance,R-HSA-422475,reactome,TRPC1
Axon guidance,R-HSA-422475,reactome,DUSP16
Axon guidance,R-HSA-422475,reactome,SCN7A
Axon guidance,R-HSA-422475,reactome,CACNA1G
Axon guidance,R-HSA-422475,reactome,DUSP5
Ephrin signaling,R-HSA-3928664,reactome,PAK3
SHC1 events in EGFR signaling,R-HSA-180336,reactome,NRG1
SHC1 events in EGFR signaling,R-HSA-180336,reactome,DUSP16
SHC1 events in EGFR signaling,R-HSA-180336,reactome,DUSP5
SHC1 events in EGFR signaling,R-HSA-180336,reactome,DLG4
SHC1 events in EGFR signaling,R-HSA-180336,reactome,EGF
SHC1 events in EGFR signaling,R-HSA-180336,reactome,IL17RD
FCERI mediated MAPK activation,R-HSA-2871796,reactome,IL17RD
FCERI mediated MAPK activation,R-HSA-2871796,reactome,EGF
FCERI mediated MAPK activation,R-HSA-2871796,reactome,NRG1
FCERI mediated MAPK activation,R-HSA-2871796,reactome,DUSP16
FCERI mediated MAPK activation,R-HSA-2871796,reactome,DUSP5
FCERI mediated MAPK activation,R-HSA-2871796,reactome,DLG4
NRIF signals cell death from the nucleus,R-HSA-205043,reactome,NGFR
M Phase,R-HSA-68886,reactome,TUBA4A
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,DLG4
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,GNG7
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,GRPR
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,DUSP5
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,F2R
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,PLCB4
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,EGF
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,GNB5
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,NRG1
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,DGKA
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,PROK1
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,DUSP16
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,IL17RD
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907,reactome,OXTR
Pentose phosphate pathway (hexose monophosphate shunt),R-HSA-71336,reactome,PGM2
Prostanoid ligand receptors,R-HSA-391908,reactome,PTGER3
p75NTR recruits signalling complexes,R-HSA-209543,reactome,NGFR
Metabolism,R-HSA-1430728,reactome,ACSM3
Metabolism,R-HSA-1430728,reactome,CACNB2
Metabolism,R-HSA-1430728,reactome,CA12
Metabolism,R-HSA-1430728,reactome,ACOT2
Metabolism,R-HSA-1430728,reactome,PLCB4
Metabolism,R-HSA-1430728,reactome,ADRA2A
Metabolism,R-HSA-1430728,reactome,ABCC3
Metabolism,R-HSA-1430728,reactome,FHL2
Metabolism,R-HSA-1430728,reactome,GNG7
Metabolism,R-HSA-1430728,reactome,CHSY1
Metabolism,R-HSA-1430728,reactome,LARS
Metabolism,R-HSA-1430728,reactome,NPAS2
Metabolism,R-HSA-1430728,reactome,HPSE2
Metabolism,R-HSA-1430728,reactome,LIPE
Metabolism,R-HSA-1430728,reactome,INPP1
Metabolism,R-HSA-1430728,reactome,PPT2
Metabolism,R-HSA-1430728,reactome,ACADS
Metabolism,R-HSA-1430728,reactome,SLC9A1
Metabolism,R-HSA-1430728,reactome,AK5
Metabolism,R-HSA-1430728,reactome,ABCB1
Metabolism,R-HSA-1430728,reactome,STAB2
Metabolism,R-HSA-1430728,reactome,SCD5
Metabolism,R-HSA-1430728,reactome,PFKP
Metabolism,R-HSA-1430728,reactome,GNB5
Metabolism,R-HSA-1430728,reactome,SLC44A1
Metabolism,R-HSA-1430728,reactome,PNPLA7
Metabolism,R-HSA-1430728,reactome,PHKG2
Metabolism,R-HSA-1430728,reactome,CACNA1C
Metabolism,R-HSA-1430728,reactome,SGPP1
Metabolism,R-HSA-1430728,reactome,PGM2
Metabolism,R-HSA-1430728,reactome,PNPLA2
Metabolism,R-HSA-1430728,reactome,ASNS
Metabolism,R-HSA-1430728,reactome,NT5C2
Metabolism,R-HSA-1430728,reactome,PIP5K1A
Metabolism,R-HSA-1430728,reactome,HS6ST1
Metabolism,R-HSA-1430728,reactome,BHMT2
Metabolism,R-HSA-1430728,reactome,GSTM5
Metabolism,R-HSA-1430728,reactome,ISYNA1
Metabolism,R-HSA-1430728,reactome,DMGDH
Metabolism,R-HSA-1430728,reactome,PIK3C2G
Effects of PIP2 hydrolysis,R-HSA-114508,reactome,DGKA
Infectious disease,R-HSA-5663205,reactome,SV2A
Neuronal System,R-HSA-112316,reactome,GRIA4
Neuronal System,R-HSA-112316,reactome,KCNMB1
Neuronal System,R-HSA-112316,reactome,CACNB1
Neuronal System,R-HSA-112316,reactome,GNB5
Neuronal System,R-HSA-112316,reactome,KCNMA1
Neuronal System,R-HSA-112316,reactome,GNG7
Neuronal System,R-HSA-112316,reactome,DLG4
Neuronal System,R-HSA-112316,reactome,CACNB2
Neuronal System,R-HSA-112316,reactome,SLC17A7
Neuronal System,R-HSA-112316,reactome,ABAT
SUMOylation of transcription factors,R-HSA-3232118,reactome,PIAS1
Basal cell carcinoma,5217,kegg,GLI2
Basal cell carcinoma,5217,kegg,GLI3
Amoebiasis,5146,kegg,LAMA1
Amoebiasis,5146,kegg,COL4A6
Amoebiasis,5146,kegg,ACTN1
Amoebiasis,5146,kegg,PLCB4
Amoebiasis,5146,kegg,TGFB2
Galactose metabolism,52,kegg,PGM2
Galactose metabolism,52,kegg,PFKP
Pancreatic cancer,5212,kegg,CDK4
Pancreatic cancer,5212,kegg,EGF
Pancreatic cancer,5212,kegg,TGFB2
Nicotine addiction,5033,kegg,SLC17A7
Nicotine addiction,5033,kegg,GRIA4
Sphingolipid metabolism,600,kegg,SGPP1
Pyrimidine metabolism,240,kegg,POLR1B
Pyrimidine metabolism,240,kegg,NT5C2
Nitrogen metabolism,910,kegg,CA12
"Alanine, aspartate and glutamate metabolism",250,kegg,ASNS
"Alanine, aspartate and glutamate metabolism",250,kegg,ABAT
Cysteine and methionine metabolism,270,kegg,BHMT2
Malaria,5144,kegg,TGFB2
Chronic myeloid leukemia,5220,kegg,CDK4
Chronic myeloid leukemia,5220,kegg,TGFB2
beta-Alanine metabolism,410,kegg,ABAT
Glioma,5214,kegg,IGF1R
Glioma,5214,kegg,EGF
Glioma,5214,kegg,CDK4
Glioma,5214,kegg,PDGFA
Purine metabolism,230,kegg,POLR1B
Purine metabolism,230,kegg,PGM2
Purine metabolism,230,kegg,AK5
Purine metabolism,230,kegg,NT5C2
Retinol metabolism,830,kegg,ALDH1A2
Retinol metabolism,830,kegg,DHRS3
Alzheimer's disease,5010,kegg,PLCB4
Alzheimer's disease,5010,kegg,CACNA1C
Pertussis,5133,kegg,C4A
Choline metabolism in cancer,5231,kegg,SLC44A1
Choline metabolism in cancer,5231,kegg,EGF
Choline metabolism in cancer,5231,kegg,PIP5K1A
Choline metabolism in cancer,5231,kegg,PDGFA
Choline metabolism in cancer,5231,kegg,DGKA
Choline metabolism in cancer,5231,kegg,SLC22A4
Dilated cardiomyopathy (DCM),5414,kegg,DES
Dilated cardiomyopathy (DCM),5414,kegg,CACNB2
Dilated cardiomyopathy (DCM),5414,kegg,TPM4
Dilated cardiomyopathy (DCM),5414,kegg,CACNA2D1
Dilated cardiomyopathy (DCM),5414,kegg,ITGA3
Dilated cardiomyopathy (DCM),5414,kegg,CACNA1C
Dilated cardiomyopathy (DCM),5414,kegg,TGFB2
Dilated cardiomyopathy (DCM),5414,kegg,CACNB1
Non-small cell lung cancer,5223,kegg,CDK4
Non-small cell lung cancer,5223,kegg,EGF
Hepatitis C,5160,kegg,PIAS1
Hepatitis C,5160,kegg,CLDN11
Hepatitis C,5160,kegg,EGF
Influenza A,5164,kegg,NXF1
Influenza A,5164,kegg,TNFRSF10B
Glycosaminoglycan degradation,531,kegg,HPSE2
Transcriptional misregulation in cancer,5202,kegg,PER2
Transcriptional misregulation in cancer,5202,kegg,IGF1R
Transcriptional misregulation in cancer,5202,kegg,NR4A3
Transcriptional misregulation in cancer,5202,kegg,NGFR
Transcriptional misregulation in cancer,5202,kegg,PDGFA
Toxoplasmosis,5145,kegg,TGFB2
Toxoplasmosis,5145,kegg,LAMA1
MicroRNAs in cancer,5206,kegg,TP63
MicroRNAs in cancer,5206,kegg,ABCB1
MicroRNAs in cancer,5206,kegg,TGFB2
MicroRNAs in cancer,5206,kegg,SLC7A1
MicroRNAs in cancer,5206,kegg,PDGFA
MicroRNAs in cancer,5206,kegg,MMP16
MicroRNAs in cancer,5206,kegg,TNC
Inflammatory bowel disease (IBD),5321,kegg,IL4R
Inflammatory bowel disease (IBD),5321,kegg,TGFB2
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,ITGA3
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,CACNB2
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,CACNB1
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,DES
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,CACNA2D1
Arrhythmogenic right ventricular cardiomyopathy (ARVC),5412,kegg,CACNA1C
Fatty acid elongation,62,kegg,ACOT2
Fatty acid elongation,62,kegg,PPT2
Type I diabetes mellitus,4940,kegg,PTPRN
Lysosome,4142,kegg,PPT2
Staphylococcus aureus infection,5150,kegg,C4A
Staphylococcus aureus infection,5150,kegg,CFI
Fluid shear stress and atherosclerosis,5418,kegg,PDGFA
Fluid shear stress and atherosclerosis,5418,kegg,GSTM5
Fluid shear stress and atherosclerosis,5418,kegg,THBD
AGE-RAGE signaling pathway in diabetic complications,4933,kegg,THBD
AGE-RAGE signaling pathway in diabetic complications,4933,kegg,COL4A6
AGE-RAGE signaling pathway in diabetic complications,4933,kegg,PLCB4
AGE-RAGE signaling pathway in diabetic complications,4933,kegg,CDK4
AGE-RAGE signaling pathway in diabetic complications,4933,kegg,TGFB2
Glutathione metabolism,480,kegg,ANPEP
Glutathione metabolism,480,kegg,GSTM5
Biosynthesis of unsaturated fatty acids,1040,kegg,ACOT2
Biosynthesis of unsaturated fatty acids,1040,kegg,SCD5
Measles,5162,kegg,TNFRSF10B
Measles,5162,kegg,CDK4
Fructose and mannose metabolism,51,kegg,PFKP
Prostate cancer,5215,kegg,EGF
Prostate cancer,5215,kegg,PDGFA
Prostate cancer,5215,kegg,IGF1R
Glycerolipid metabolism,561,kegg,PNPLA2
Glycerolipid metabolism,561,kegg,DGKA
Glycerolipid metabolism,561,kegg,PPAPDC1B
Starch and sucrose metabolism,500,kegg,TREH
Starch and sucrose metabolism,500,kegg,AMY2A
Starch and sucrose metabolism,500,kegg,AMY1A
Starch and sucrose metabolism,500,kegg,PGM2
Mucin type O-glycan biosynthesis,512,kegg,GALNT10
Viral carcinogenesis,5203,kegg,YWHAQ
Viral carcinogenesis,5203,kegg,ACTN1
Viral carcinogenesis,5203,kegg,CDK4
Tight junction,4530,kegg,TUBA4A
Tight junction,4530,kegg,CLDN11
Tight junction,4530,kegg,ACTN1
Tight junction,4530,kegg,CDK4
Cell cycle,4110,kegg,TGFB2
Cell cycle,4110,kegg,CDC14A
Cell cycle,4110,kegg,CDK4
Cell cycle,4110,kegg,YWHAQ
Breast cancer,5224,kegg,CSNK1A1
Breast cancer,5224,kegg,CDK4
Breast cancer,5224,kegg,EGF
Breast cancer,5224,kegg,IGF1R
Breast cancer,5224,kegg,LRP6
Renal cell carcinoma,5211,kegg,PAK3
Renal cell carcinoma,5211,kegg,TGFB2
Colorectal cancer,5210,kegg,TGFB2
Chemical carcinogenesis,5204,kegg,GSTM5
Hypertrophic cardiomyopathy (HCM),5410,kegg,TGFB2
Hypertrophic cardiomyopathy (HCM),5410,kegg,CACNB2
Hypertrophic cardiomyopathy (HCM),5410,kegg,CACNA1C
Hypertrophic cardiomyopathy (HCM),5410,kegg,CACNB1
Hypertrophic cardiomyopathy (HCM),5410,kegg,ITGA3
Hypertrophic cardiomyopathy (HCM),5410,kegg,DES
Hypertrophic cardiomyopathy (HCM),5410,kegg,TPM4
Hypertrophic cardiomyopathy (HCM),5410,kegg,CACNA2D1
Pathogenic Escherichia coli infection,5130,kegg,TUBA4A
Pathogenic Escherichia coli infection,5130,kegg,YWHAQ
"Valine, leucine and isoleucine degradation",280,kegg,ACADS
"Valine, leucine and isoleucine degradation",280,kegg,ABAT
Tuberculosis,5152,kegg,TGFB2
Tuberculosis,5152,kegg,IRAK2
Endocytosis,4144,kegg,PIP5K1A
Endocytosis,4144,kegg,EHD2
Endocytosis,4144,kegg,IGF1R
Endocytosis,4144,kegg,SMURF2
Hepatitis B,5161,kegg,YWHAQ
Hepatitis B,5161,kegg,CDK4
Hepatitis B,5161,kegg,TGFB2
Drug metabolism,982,kegg,GSTM5
Fatty acid degradation,71,kegg,ACADS
Amino sugar and nucleotide sugar metabolism,520,kegg,PGM2
Hepatocellular carcinoma,5225,kegg,CSNK1A1
Hepatocellular carcinoma,5225,kegg,TGFB2
Hepatocellular carcinoma,5225,kegg,GSTM5
Hepatocellular carcinoma,5225,kegg,CDK4
Hepatocellular carcinoma,5225,kegg,LRP6
Hepatocellular carcinoma,5225,kegg,IGF1R
HTLV-I infection,5166,kegg,TGFB2
HTLV-I infection,5166,kegg,PDGFA
HTLV-I infection,5166,kegg,CDK4
Inositol phosphate metabolism,562,kegg,PLCB4
Inositol phosphate metabolism,562,kegg,INPP1
Inositol phosphate metabolism,562,kegg,PIP5K1A
Inositol phosphate metabolism,562,kegg,ISYNA1
Inositol phosphate metabolism,562,kegg,PIK3C2G
Regulation of actin cytoskeleton,4810,kegg,PAK3
Regulation of actin cytoskeleton,4810,kegg,SLC9A1
Regulation of actin cytoskeleton,4810,kegg,MYLK
Regulation of actin cytoskeleton,4810,kegg,EGF
Regulation of actin cytoskeleton,4810,kegg,ITGA3
Regulation of actin cytoskeleton,4810,kegg,F2R
Regulation of actin cytoskeleton,4810,kegg,PDGFA
Regulation of actin cytoskeleton,4810,kegg,PIP5K1A
Regulation of actin cytoskeleton,4810,kegg,ACTN1
Propanoate metabolism,640,kegg,ABAT
Thiamine metabolism,730,kegg,AK5
Human papillomavirus infection,5165,kegg,RELN
Human papillomavirus infection,5165,kegg,COL4A6
Human papillomavirus infection,5165,kegg,CSNK1A1
Human papillomavirus infection,5165,kegg,TNC
Human papillomavirus infection,5165,kegg,LAMA1
Human papillomavirus infection,5165,kegg,CDK4
Human papillomavirus infection,5165,kegg,EGF
Human papillomavirus infection,5165,kegg,ITGA3
Apoptosis,4215,kegg,NGFR
Focal adhesion,4510,kegg,ITGA3
Focal adhesion,4510,kegg,ACTN1
Focal adhesion,4510,kegg,IGF1R
Focal adhesion,4510,kegg,PDGFA
Focal adhesion,4510,kegg,RELN
Focal adhesion,4510,kegg,LAMA1
Focal adhesion,4510,kegg,TNC
Focal adhesion,4510,kegg,EGF
Focal adhesion,4510,kegg,PAK3
Focal adhesion,4510,kegg,MYLK
Focal adhesion,4510,kegg,COL4A6
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,563,kegg,PIGL
Metabolism of xenobiotics by cytochrome P450,980,kegg,GSTM5
Huntington's disease,5016,kegg,PLCB4
Huntington's disease,5016,kegg,DLG4
p53 signaling pathway,4115,kegg,CDK4
p53 signaling pathway,4115,kegg,TNFRSF10B
Oocyte meiosis,4114,kegg,IGF1R
Oocyte meiosis,4114,kegg,YWHAQ
Phagosome,4145,kegg,TUBA4A
Butanoate metabolism,650,kegg,ACSM3
Butanoate metabolism,650,kegg,ABAT
Butanoate metabolism,650,kegg,ACADS
Adherens junction,4520,kegg,IGF1R
Adherens junction,4520,kegg,ACTN1
African trypanosomiasis,5143,kegg,PLCB4
Epstein-Barr virus infection,5169,kegg,YWHAQ
Alcoholism,5034,kegg,GNG7
Alcoholism,5034,kegg,FOSB
Alcoholism,5034,kegg,GNB5
"Glycine, serine and threonine metabolism",260,kegg,DMGDH
Small cell lung cancer,5222,kegg,ITGA3
Small cell lung cancer,5222,kegg,LAMA1
Small cell lung cancer,5222,kegg,COL4A6
Small cell lung cancer,5222,kegg,CDK4
Gap junction,4540,kegg,TUBA4A
Gap junction,4540,kegg,PLCB4
Gap junction,4540,kegg,PDGFA
Gap junction,4540,kegg,EGF
Rheumatoid arthritis,5323,kegg,TGFB2
Autophagy,4140,kegg,IGF1R
N-Glycan biosynthesis,510,kegg,ALG13
Cellular senescence,4218,kegg,CDK4
Cellular senescence,4218,kegg,TGFB2
Kaposi's sarcoma-associated herpesvirus infection,5167,kegg,CDK4
Kaposi's sarcoma-associated herpesvirus infection,5167,kegg,GNG7
Kaposi's sarcoma-associated herpesvirus infection,5167,kegg,GNB5
Leishmaniasis,5140,kegg,TGFB2
Pentose phosphate pathway,30,kegg,PGM2
Pentose phosphate pathway,30,kegg,PFKP
Proteoglycans in cancer,5205,kegg,SLC9A1
Proteoglycans in cancer,5205,kegg,TGFB2
Proteoglycans in cancer,5205,kegg,IGF1R
Proteoglycans in cancer,5205,kegg,HPSE2
Glycolysis / Gluconeogenesis,10,kegg,PFKP
Glycolysis / Gluconeogenesis,10,kegg,PGM2
Glycerophospholipid metabolism,564,kegg,PPAPDC1B
Glycerophospholipid metabolism,564,kegg,DGKA
Glycerophospholipid metabolism,564,kegg,PNPLA7
Cocaine addiction,5030,kegg,FOSB
Cocaine addiction,5030,kegg,DLG4
Apoptosis,4210,kegg,TUBA4A
Apoptosis,4210,kegg,TNFRSF10B
Bladder cancer,5219,kegg,CDK4
Bladder cancer,5219,kegg,EGF
Type II diabetes mellitus,4930,kegg,CACNA1G
Type II diabetes mellitus,4930,kegg,CACNA1C
Necroptosis,4217,kegg,TNFRSF10B
Amphetamine addiction,5031,kegg,FOSB
Amphetamine addiction,5031,kegg,GRIA4
Amphetamine addiction,5031,kegg,CACNA1C
Glycosaminoglycan biosynthesis,532,kegg,CHSY1
Endometrial cancer,5213,kegg,EGF
Nicotinate and nicotinamide metabolism,760,kegg,NT5C2
Acute myeloid leukemia,5221,kegg,PER2
Glycosaminoglycan biosynthesis,534,kegg,HS6ST1
Morphine addiction,5032,kegg,GNB5
Morphine addiction,5032,kegg,GNG7
Signaling pathways regulating pluripotency of stem cells,4550,kegg,LIF
Signaling pathways regulating pluripotency of stem cells,4550,kegg,LIFR
Signaling pathways regulating pluripotency of stem cells,4550,kegg,IGF1R
Melanoma,5218,kegg,PDGFA
Melanoma,5218,kegg,EGF
Melanoma,5218,kegg,CDK4
Melanoma,5218,kegg,IGF1R
Pathways in cancer,5200,kegg,F2R
Pathways in cancer,5200,kegg,PDGFA
Pathways in cancer,5200,kegg,IGF1R
Pathways in cancer,5200,kegg,ITGA3
Pathways in cancer,5200,kegg,TGFB2
Pathways in cancer,5200,kegg,CDK4
Pathways in cancer,5200,kegg,COL4A6
Pathways in cancer,5200,kegg,GLI3
Pathways in cancer,5200,kegg,EGF
Pathways in cancer,5200,kegg,GLI2
Pathways in cancer,5200,kegg,GNG7
Pathways in cancer,5200,kegg,GNB5
Pathways in cancer,5200,kegg,LAMA1
Pathways in cancer,5200,kegg,PLCB4
Pathways in cancer,5200,kegg,PTGER3
Systemic lupus erythematosus,5322,kegg,C4A
Systemic lupus erythematosus,5322,kegg,ACTN1
Chagas disease (American trypanosomiasis),5142,kegg,TGFB2
Chagas disease (American trypanosomiasis),5142,kegg,PLCB4
Herpes simplex infection,5168,kegg,PER2
Herpes simplex infection,5168,kegg,NXF1
Central carbon metabolism in cancer,5230,kegg,PFKP
